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Abstract
Applications nanomaterials in biology resulted in many exciting fields of research such as
nanomedicine, nanotheraputics and bionanosensors. The development of these fields highly
depends on the nature and stability of nanomaterials in biological fluids. The poor stability of
nanomaterials in biological media due to the aggregation and/or agglomeration with the
biomolecules, particularly with serum proteins, is a challenging problem. Conversely, the
defined formation of protein corona around the nanomaterials is very useful to improve
properties such as cellular uptake and compatibility of the materials. The primary goal of this
thesis will be to design and develop methods for biologically stable, nontoxic nanomaterials. In
specific, the project is designed to biofunctionalize 2D nanolayers such as graphene and use
the resulting materials in biology. The initial aims of this study was focused on the utility of
graphene as a platform for the design of ‘stable–on-the-table’ biomaterials using the wellestablished techniques in our lab. The developments in this study will lead to the engineering of
enzymatic biofuel cells with improved power density and sustainability. The second part of the
project is to produce graphene in large quantities, in aqueous media using proteins as
exfoliators. The produced graphene, called biographene, was characterized and used to
evaluate the protein binding capabilities. Finally, graphene and other 2D analogues, such as
Boron nitride (BN), Molybdenum sulfide (MoS2) and Zirconium phosphate (ZrP), will be
exfoliated in animal serum. Production and characterization of the layered materials in serum
from bovine, porcine, chicken, rat, human and so on will be executed and the in vivo and in vitro
toxicity will be tested for specific samples.
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Introduction: Recent Advances in Biological interaction of 2D
Nanomaterials

Applications of nanomaterials in biology stemmed in many exciting fields of research such
as nanomedicine, nanotheraputics and bionanosensors.1 The development of these fields highly
depends on the stability and toxicity of materials in biological systems.2 Stabilizing
nanomaterials in biological media without harmful capping or stabilizing agents is an
unaddressed challenge, which require immediate attention for the rapid development in the
field. The major challenge in stabilizing these materials in protein rich biofluids is the nonspecific adsorption of serum proteins, commonly known as protein corona, because this is
initially noted for spherical nanoparticles.2

The consequences of corona formation are 1) binding of nanomaterials to non-targeted
areas in drug delivery,3 2) aggregation induced precipitation of materials which could lead to
lodges in veins or lungs 4 and 3) non-specific binding in biosensors. 5

Modification with

hydrophilic polymers such as poly (etheleneglycol) (PEG) on nanosurface prevents non-specific
5

adsorption to certain extent, but not completely. Also, PEG functionalization (PEGylation)
requires another step in the design of nanomaterials, where the material has to be amenable to
the PEGylation conditions. Biological functionalization of nanosurface is another novel way to
improve biological properties of nanomaterials.

1
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Modification of nanosurfaces with biomolecules such as proteins, nucleic acids, and
carbohydrates is recently used to improve the colloidal stability and compatibility of
nanomaterials. 6 Both covalent and non-covalent chemistry can be used to biofunctionalize
nanosurfaces, which can be post-modification or in situ at the synthesis step. Profound
understanding of the interface of biomolecule and nanosurface is the basis for such
modifications and manipulations of these functionalized materials. With the help of advanced
spectroscopic and microscopic techniques, an overview of recent improvements in this field is
described below.

1.1.

Surface Chemistry of Nanolayers

Chemistry of nanomaterials is mostly controlled by elemental composition at the surface, the
surface groups, particle size, area per unit mass etc. Ligands bound to nano layers function as a
stabilizing agents in solution and to tune the size and optoelectronic nature by controlling the
bulkiness, chain length and chemical reactivity of the ligand.7 Nano layered materials usually
possess surface functional groups, which stabilizes the nanosurface in colloidal form, present
within its chemical structure. This is true for a class of materials known as layered double
hydroxides 8 layered phosphates and phosphonates where charged hydroxides or phosphate
groups provide charge separation between individual layers in solution. 9 Although these
materials have colloidal stability by electrostatic repulsions, stabilizing agents are usually
required for long term stability.10,11

Recent invention of single layer graphene paid much attention due to unexpected stability of
single atom thick carbon layers, without folding or scrolling to low surface energy sphere or tube
like structures.12 Graphene was stable on different substrates such as Si wafer, Cu and also in
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solutions phase in specific organic solvents.13,14 The dispersive property of graphene in water
was extremely poor due to the inherent hydrophobicity of carbon.15 However, the oxidized from
of graphene called graphene oxide (GO) possess oxygen functional groups to provide enough
surface charge for aqueous stability. 16 After the invention of graphene materials such as
transition metal dichalogenides (TMDs), h-Boron Nitride, MXenes and many more are
synthesized or prepared from the bulk.17,18,19 Exciting features of these materials are known or
yet to be discovered for advanced electronics and functional materials.

Covalent chemistry of NMs is limited to the chemistry of surface coating groups except for
strong gold-sulfur (Au-S) bonds. 20 Silica NPs can be modified using the hydroxyl group
chemistry.21 In case of nanolayers synthesized via chemical methods (top to bottom approach)
reactive groups such as –COOH and NH2 can be incorporated during synthesis. Graphene
oxide with reactive hydroxyl, carboxyl and carbonyl groups can be easily modified using
standard carbonyl chemistry. 22 The post modification of NMs is useful to control the surface
properties required to tune the optoelectronic and biological properties.

1.2.

Governing factors at Bio-Nano Interface

Macromolecular interactions between biomolecules and nanosurface are very complex because
of its multivalent nature. Both targeted and non-targeted interactions can be tailored at this
interface (Figure 1.1). Widely used specific binding strategies are mediated by streptavidinavidin (or biotin), 23 sugar-lectin, 24 antigen antibody interactions etc, which has limitations in
terms of scalability and cost.25 Also post modification with one of the components is required to
for this chemistry. However, controlling the non-targeted interactions, which does not require
complementary ligands, is challenging. Bio-Nano interactions can be molecularly controlled by
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electrostatic or weak non-covalent interactions, by appropriate design.

27

Most of these

interactions are susceptible to solvent parameters such as, pH and ionic strength.26 The major
goal in controlling Bio-Nano interaction is to conserve the function of biomolecule under these
non-physiological environments. Since the optimum activity of biomolecules are required for any
biomedical devices or techniques, control of BioNano interface (BNI) deserves much
importance.27

Non-covalent interactions at bio-nano interface using electrostatic interactions are very versatile
approach, because no post modifications are required and both the surface and the biomolecule
possess surface charges, hydrogen bonding donors and/or acceptors, hydrophobic sites etc.
(Figure 1.2). The role of solvent and counter ions at charged interfaces is thoroughly
investigated by our group and ion coupled protein binding (ICPB) mechanism was proposed.

26

according to ICPB mechanism, counter ions are released from the interface when a positive
protein interacts with negative substrate. On the other hand, sequestration of ions to the
interface is required for the interaction of a negative protein and negative surface.
Immobilization of DNA to mica surface achieved only in presence of divalent metal ions
underlines the ion sequestration mechanism.28

4
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A

B

Figure 1.1. Targeted (A) and non-targeted (B) binding at bionano interfaces. Complementary
groups are introduced at biomolecule and nanosurface for targeted binding, whereas random
binding of groups on the biomolecule to the surface groups results in non-targeted binding.

5
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Interaction between positive and negative groups by electrostatic force is used at for
applications in sensing and drug delivery using nanosurfaces. DNA or RNA with phosphate
backbone form salt bridges with amino groups in polymers (eg; polyetheleneimine), widely used
for applications such as siRNA delivery.29 On the other hand, lysine and arginine side chains
can also have affinity phosphate, carboxyl or hydroxyl groups. Covalent like nature of argininephosphate interaction is noted because of cooperative salt bridges between the groups that
from stable hexagonal structure.30 Non-charged surface biomolecule interactions usually driven
by hydrophobic and van der Waal’s forces.

Hydrophobic interactions are successfully used to control protein nanolayers interactions
particularly for hydrophobic proteins.

31

Lipase was immobilized to polystyrene and

hydrophobically modified agarose by using strong hydrophobic interactions.32 This interaction
led to the hyperactivation of enzymatic activity of lipase called as interfacial activation.
Interaction of carbon surfaces (such as in CNT, graphene or GO) with proteins, peptides or DNA
is also hydrophobic in nature. 33 Because of the same, proteins tend to denature on GO by
exposing the inner hydrophobic amino acids in the secondary structure. 34 The hydrophobic
interaction between graphene and DNA was used to fabricate ‘turn-on’ fluorescent sensors.35
The mechanistic aspect of hydrophobic interactions provide another key to control this
interactions.

6
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A

C

B

D

Figure 1.2. Major non-targeted interactions at Bio-nanolayer interfaces.
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The hydrophobic interaction of proteins with substrates was proposed to be entropic in
nature. 36 Interaction of hydrophobic surfaces water molecules and counter ions from the
interface moves to the bulk results in increase in entropy of water and ions. This mechanism is
supported by measuring water diffusion constant at the interfaces of mussel foot protein (mfp)
on surfaces.37 When weakly hydrated amino acids in the protein approaches to hydrophobic
styrene surface, strong eviction of water molecules from the surface. As a result, diffusion time
of water at the interface increased from 335 to 842 ps at pH 5.5). The role of water in
hydrophobic interactions is irrefutable but actual thermodynamics behind this interaction is a
mystery.38

Interactions at BNI are also influenced by heterogeneity, edges, roughness and defects at
the surfaces.

27

There could also be hot spot residues on the protein or DNA, which strongly

interacts with the surfaces.39 More efforts in this area with the help of computational analysis
needed to define interactions at BNI in future.

1.3.

Biological Functionalization of Nanolayers

Surface functionalization of NMs with biomolecules to improve its biological or non-biological
function is usually termed as biofunctionalization. 40 Biofunctionalization can be executed to
nanomaterials either in situ or by post modification steps, and the latter one is the most common
approach. Post modification is recommended when biomolecule does interfere with the
synthesis of nanomaterial. Also any biological activity of the capping agent can be avoided by
substituting them with biomolecules at the post modification step.41 The disadvantage with the
post modification is the lack of stability of nanomaterials to the biological molecules or fluids.
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When NMs are introduced to biofluids, serum proteins segregate around the nanosurface called
as biocorona (or protein corona) formation.42

Protein corona on nanosurface causes significant increase in size and interferes with the
surface chemistry of the material.

42

On contrary, studies protein corona masks the toxicity of the

material by reducing the exposure of the materials to the biological systems. 43 But protein
corona severely affects the specificity of the nanomaterials, if they are targeted to a specific
region or cells.44 The field of nanomedicine faces a big challenge in recent times due to the nonspecific nature of the nanoparticles in biological fluids. A new study shows that only 0.7% of the
total nanomaterial loaded with drug molecules, injected to an in vivo system has delivered to the
targeted region (average of 117 independent experiments).45 This mean 99.3% of the particles
are accumulated in the other part of the body; usually spleen, liver or kidney causes damage to
the organ or ends up in mortality of the animal. These findings point out to the need of
biofunctionalization to keep the nanoparticle intact in body fluids before going to in vivo models.
Another consequences of protein corona formation is the accumulation of nanomaterials in liver,
spleen and kidney, causes acute or chronic toxic effects.

9
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Figure 1.3. Bio-corona formation on nanolayers and its consequences.
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Nanotoxicity is a major concern in nanotechnology field for last two decades, particularly for
materials with applications in biomedical and environmental applications. 46 Well dispersed
nanomaterials in cell culture or blood stream of an in vivo organism is necessary to evaluate the
extent toxicity. However, aggregation or agglomeration of the materials driven by corona
formation interferes the toxicity analysis and overestimated exposure levels may be reported.47
In other words, aggregated portion of the material will not be in contact with the cell or animal
will also be taken in account in the dose dependent studies. For example, assume that 50% of
the material precipitates when added to cell culture media and the remaining 50% is well
dispersed. The well-dispersed portion is responsible for the toxicity to the cells because it is in
contact. But the reported dose for the exposure of the nanomaterial will be reported for 100%,
although 50% were inert. It is also noted that dispersible portion of the aggregated nanoparticles
are more toxic than well-dispersed particles in case of carbon nanotubes.48 This inconsistency
in evaluation nanotoxicity of materials from the lack of colloidal stability can be solved by
appropriate biofunctionalization.

Preparation of NMs in or with the help of biomolecules is a probable solution to the
challenges associated with corona formation. Unfortunately, few attempts are done this area
and those materials are rarely used for application or toxicity analysis. Nanoparticles and
nanoclusters of gold and silver particles are synthesized using proteins or DNA.49 For example,
gold nano clusters are synthesized using the reactivity of cysteine residue (34th position) in
BSA. 50 Nanolayered materials are delaminated from the bulk using proteins as exfoliating
agents, where the 3D structure of the protein prevents the individual layers from aggregation.
The avenue of biomolecules and NMs offer opportunities to explore new green synthetic routes
for well-dispersed materials in biofluids.
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1.4. Toxicity of Nanolayers

Toxic effects of NMs to humans and environment became a major concern after the nanorevolution in the past few decades. 51 The adverse effect of NMs on living organisms and
environment is different from that of molecules because of their size, shape and surface
chemistry.52 Primarily, the biological effects of NMs are usually studied using mammalian cells
as model systems. Most of these studies are carried out to analyze the cytotoxicity of NMs to
cell lanes, after incubating certain doses of the material with the cell media. Nanoparticles are
widely studied systems to evaluate the toxic effect of NMs and the effect of size, surface
functionalization is noted. Toxicity of layered materials is initially examined for nanoclay
materials.53

Nanoclay materials are found to be little or no toxicity in in vivo models.54 Recent invention
of graphene and related materials resulted in toxicity analysis of these layered materials in
detail. Both in vivo and in vitro models suggest that oxidized graphene derivates, called
graphene oxide (GO) and reduced GO (rGO) is very toxic to the model systems (Table 1.1).
Most of the studies indicates the generation of reactive oxygen species in the presence of these
materials, leading to cell death or inflammation. Since GO is defective and mass production is
limited because of the synthetic requirements, dispersible graphene is particularly attractive.

Toxicity study of graphene is well known in the field because of low availability of water
dispersible graphene. However, studies using aggregated graphene and polymer supported
graphene showing inconsistent results (Table 1.1). In general, well-dispersed graphene (in
polymer solutions) are less toxic comparable aggregated graphene platelets in solution. These
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studies point out to the need of well dispersed carbon materials in biological fluids to improve
the biocompatibility of graphene and its derivatives.

Table 1.1. Toxicity of Graphene tested in in vitro and in vitro models

Material

Properties

Model

Dose

Results

3-5 layers
Graphene
Charge = (CVD)

55

36 mV (in

PC12

ROS generation,
0.1-100 µg/mL

Cells

Apoptosis induction

water)
No direct toxicity from
Graphene
graphene

Thickness

Platelets

= 5 nm (5(Sonication in 2%

Mice

50 µg/animal

15 layers)

Well dispersed graphene
was less toxic than

56

Pluronic F108)

aggregates
Graphene Nano-

Lung and Pleural

platelets

50 μg/animal

10 nm thick

inflammation

(aspiration) 5

(Plasma
5 µm in

Mice

Frustrated phagocytocis
μg/animal

exfoliated,
size

(injection)

dispersed in 0.5%

ROS, pro inflammatory
cytokine activation

BSA)57
3-5 nm
Aggregated

Lodges the airways in
Mice

50 µg/animal

thickness

lung and induces local
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graphene

when

fibrotic response

dispersed
(Flocculation of
in 2%
graphite)58
Pluronic
acid
Multilayer
graphene
No effect on both
(Sonication of

30 layers

Nematode

50-250 µg/mL

thermally

longevity and
reproduction

expanded
graphite)59
Welldispersed
NanoGO-PEG

nanoGOPEG
HCT-116

(Hummers
Method)60

0.5-150 µg/mL

No or reduced toxicity

5-50 nm
size

Single layer GO

(Modified
Hummers

No toxicity up to 100
µg/mL

<500 nm
A549

8-125 µg/mL

size

Toxicity due to synthetic

method)61

and metallic impurities
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are noted
BSA coated GO
420-860
(Hummers

No effect on metabolic
C2C12

10-100 µg/mL

nm size

activity

method)62
rGO
1.0 nm
(Hummers

20% viability at 85
A549

20-85 µg/mL

thickness

µg/mL

/Hydrazine)63
rGO
Less platelet

Bilayer
(Hummers/
Thermal

mice

250 µg/kg

0.2-5 µm

aggregation compared to
GO

reduction)64

1.5. Conclusions, Challenges and Perspectives

Understanding of bionano interface in a profound manner is necessary for the applications
of nanomaterial in cell biology, biomedical field and in nanomedicine. The applications of NMs in
biological filed is highly depend on two factors 1) stability of NMs in biological media and 2)
toxicity of NMs to cells or animals. Stability of nanomaterials in biological media is poor because
of protein corona formation, which also affects the performance of NM in the system by masking
the target sites in the NMs. The corona formation can overcome by appropriate post
5

modifications and in situ biofunctionalization of NMs. Manipulation of BNI at molecular level is
needed for these functionalization strategies. Concerns about nanotoxicity is the other avenue
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hampering the biological applications of NMs. Studies show that layered materials are toxic or
nontoxic based on their composition (Table 1.1). Large interest in graphene materials motivated
several groups to evaluate material toxicity of GO, rGO and pristine graphene. Graphene
platelets and aggregated found to be less toxic compared to oxidized counterparts. However,
several inconsistencies in graphene toxicity analysis is noted in many cases, originated because
of poor dispersive properties. Major attention is needed in this field to define the toxicity of
graphene under completely dispersed graphene in biological liquids and the role of dispersibility,
size, number of layers, extent of oxidation and defects is also need to be documented. This is
possible only by preparation these materials under biologically benign conditions with minimum
chemical treatments. Bioengineering of NMs becomes extremely relevant in this context.

1.6.

Properties of proteins used in this thesis

Protein

pI /net
charge at pH
7

4.6/-27

Mol. Wt.
(kDa)

Key amino acid
composition

160

Lys – 30
Arg – 22
Asp – 36
Glu – 30

34

Lys – 6
Arg – 21
Asp – 21
Glu – 7

Glucose Oxidase (GOx)65
(Aspergillus niger)

6.3/-1

Horseradish peroxidase (HRP)66
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5.6/-17

66

Lys – 59
Arg – 23
Asp – 40
Glu – 59

Bovine Serum Albumin (BSA)67

10/+13

26

Lys – 32
Arg – 4
Asp – 10
Glu – 13

Cytochrome c68
(equine heart)

11.3/+8

14

Lys – 6
Arg – 11
Asp – 7
Glu – 2

Lysozyme (Lyz)69
(Chicken egg)

6.8/+1

Bovine Hemoglobin (Hb)70

17

62

Lys – 48
Arg – 14
Asp – 34
Glu – 26
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5.1/-18

37

Lys – 30
Arg – 6
Asp – 20
Glu – 16

Beta-lactoglobulin (BLG)
(Bovine Milk)71

6.8/0

17

Lys – 19
Arg – 2
Asp – 8
Glu – 13

Bovine Myoglobin (Mb)72

4.9/-12

43

Lys – 20
Arg – 15
Asp – 14
Glu – 33

Ovalbumin (OVL)
(Chicken egg)73

1/-40

Bovine Pepsin A (PepA)74

18

35

Lys – 1
Arg – 2
Asp – 30
Glu – 13
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9.3/+7

30

Lys – 18
Arg – 8
Asp – 8
Glu – 6

Bovine Trypsin (Trp)75

60
5.4/-5
(mono)

Lys – 28
Arg – 32
Asp – 39
Glu – 26

Bovine Catalase (Cat)76

4.7/-15

66

Lys – 59
Arg – 24
Asp – 36
Glu – 62

Human Serum Albumin (HSA)77

5.3/-24

46

Cellulase

Lys – 13
Arg – 7
Asp – 24
Glu – 20

(Trichoderma reesei)78

9.3/+4
RNase A79
(Bovine)

19

14

Lys – 10
Arg – 4
Asp – 5
Glu – 5
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1.7.

Properties of Materials used in this thesis

1. a - Zirconium Phosphate (a - ZrP)

a - ZrP is phosphate based layered material with general Formula Zr(HPO4)2·nH2O. The
structure of a - ZrP composed for hexavalent Zr(IV) cation, bridged to tetravalent phosphorous
atom through divalent oxygens (Figure 1.4.A). In the crystal structure, a - ZrP layers stack
where the phosphate groups are facing each other (Figure 1.4.B), with 7.6 Å interlayer
distance.80 Free oxygen atoms exposed to the solvent, when exfoliated attributed to the stability
of layered structure in solution. Phosphate groups the structure results in unit negative charge in
every very 24 Å2 area, when deprotonated.81 The surface charge of a - ZrP makes it attractive
for electrostatic interactions with metal ions, proteins, DNA and small molecules.

Key Properties

Surface Area: 2.4 m2/g (BET)82
Proton conductivity: 10-5 - 10-6 s cm-1 (25°C, 90% RH)83
Zeta potential; ~ -40 mV (pH 7.0)84
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A

B

Figure 1.4.A. Structure of a - ZrP. B. Alignment of a - ZrP layers in crystal structure.

21

Chapter 1
2. Graphene Oxide

Graphene Oxide (GO) is the water dispersible graphene derivative derived from graphite via
strong oxidation procedure known as Hummers method.85 Graphene does not mix with water
because of its inherent hydrophobic nature, but the oxygen functional groups on GO provides
surface charge and hydrophilicity to the sheets makes it dispersible in water. Typically, C:O of
2.1 to 2.9 was noted for GO produced using Hummers method, and the oxygen portion present
as hydroxyl, carboxyl, and epoxy groups. 86 In a packed structure GO shows 7 Å spacing
corresponding to the carbon layers and intercalated water molecules. GO shows insulation
property in contrary to high carrier mobility of pristine graphene but the solution processability of
GO makes it attractive for wide applications in materials field.87

Key properties

Surface Area: 760 m2/g88
Electrical Resistivity: 103 kW/sq (25°C)89
Thermal Conductivity: 900 ± 45 W m−1 K−190
Young’s Modulus: ~ 207 GPa (single layer)91
Tensile Strength: 32 GPa

91

Zeta potential; ~ -50 mV (pH 7.0)92
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Figure 1.5. Structure of graphene oxide
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3. Graphene

Graphene, one atom thick sp2 carbon layers, known as the ‘wonder material’ of 21st century.
Graphene has amazing electronic and material properties compared to any existing material.
Structure of graphene can be visualized as the ultimate member of poly cyclic aromatic
hydrocarbon family. Graphene is prepared by bottom down approach from parent graphite by
exfoliation process or by bottom up approach from carbon sources (such as methane) by
chemical vapor deposition like methods.93 Key properties of graphene is noted below.

Theoretical surface area: 2360 m2/g94
Thermal conductivity: ~5000 W/mK95
Young’s modulus: ~1 TPa96
Optical transmittance: ~97.7% (single layer)

93

Tensile Strength: 130 GPa97
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Figure 1.6. Structure of graphene
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Abstract

Metal Enzyme Frameworks: Role of Metal ions in self-assembly of
proteins on α-Zirconium Phosphate Nanolayers

2.1. Abstract
Previously, ion-coupled protein binding (ICPB) model was proposed to explain the
thermodynamics of protein binding to negatively charged α-Zr(IV) phosphate (α-ZrP). This
model is tested here using glucose oxidase (GOx) and met-hemoglobin (Hb) and with several
cations (Zr(IV), Cr(III), Au(III), Al(III), Ca(II), Mg(II), Zn(II), Ni(II), Na(I), and (H(I)). The binding
constant of GOx with α-ZrP was increased ~380-fold by the addition of either 1 mM Zr(IV) or 1
mM Ca(II), and affinities followed the trend Zr(IV) ~ Ca(II) > Cr(III) > Mg(II) >> H(I) > Na(I).
Binding studies could not be conducted with Au(III), Al(III), Zn(II), Cu(II) and Ni(II), as these
precipitated both proteins. Zr(IV) increased Hb binding constant to α-ZrP by 43-fold, and affinity
enhancements followed the trend Zr(IV) > H(I) > Mg(II) > Na(I) > Ca(II) > Cr(III). Zeta potential
studies clearly showed metal ion binding to α-ZrP and affinities followed the trend, Zr(IV) >>
Cr(III) > Zn(II) > Ni(II) > Mg(II) > Ca(II) > Au(III) > Na(I) > H(I). Electron microscopy showed
highly ordered structures of protein/metal/α-ZrP intercalates on micron length scales, and
protein intercalation was also confirmed by powder XRD. Specific activities of GOx/Zr(IV)/α-ZrP
and Hb/Zr(IV)/α-ZrP ternary complexes were 2.0 x 10-3 M-1s-1 and 6.5 x 10-4 M-1s-1, respectively.
While activities of all GOx/cation/α-ZrP samples were comparable, those of Hb/cation/α-ZrP
followed the trend Mg(II) > Na(I) > H(I) > Cr(III) > Ca(II) ~ Zr(IV). Metal ions enhanced protein
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binding by orders of magnitude, as predicted by ICPB model, and binding enhancements
depended

on

charge

as

well

as

the

phosphophilicity/oxophilicity
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2.2. Introduction

Protein self-assembly at liquid-solid interfaces is of current interest and this is often achieved
via chemical1, biomolecular2, thermal3 or metal-induced assembly4,5,6. Protein self-assembly is
challenging because of the large size of proteins, multiple functional groups on their surfaces,
their fragility to solvents, sensitivity to particular ions and extreme pH, and their vulnerability to
degradation by proteases, which are ubiquitous. Protein assemblies are increasingly being
used in biosensing, 7 biomaterials, 8 biocatalysis 9 and biomedicine. 10 Therefore, it is critical to
understand how such assemblies can be constructed by a systematic approach and establish
the details of the mechanism of protein assembly, so that protein assembly can be controlled in
a rational, predictable manner. Despite the wide spread interest in the application of proteins
bound to solid surfaces, there are no quantitative models or rational approaches to address
these important issues.

The mechanism of protein binding to solid surfaces is complex and not fully understood.11
However, in the case of most water-soluble, charged proteins, protein binding requires charge
neutralization at the protein-solid interface, and this electrostatic requirement imposes the
participation of appropriately charged species (ions) in the protein binding mechanism.
Although, there have been several qualitative studies on the promotion of binding of anionic
biomolecules such as DNA to negatively charged solids such as mica,12 or other solids,13 there
have been no quantitative studies evaluating the role of metal ions in biomolecule binding to
ionic solids.

Previously, protein binding to charged solid surfaces was proposed to involve the
sequestration or release of ions at/from the protein-solid interface.14,15 That is, binding of
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negatively charged proteins to a negatively charged solid would require sequestration of cations
of proper charge, affinity and concentration to support protein binding.14,15 The ion sequestration
at the interface would neutralize the excess charge and facilitate protein assembly, and this ioncoupled protein binding (ICPB) model, where the metal ions played a critical role in protein
binding, was also supported by pH and temperature dependence studies.

15

Here, the ICPB model is tested explicitly, and we demonstrate metal-mediated binding of
two model proteins glucose oxidase (GOx) and met-hemoglobin (Hb) to anionic αZirconium(IV)phosphate (Zr(HPO4)2.H2O, abbreviated as α-ZrP.16,17 a-ZrP consists of chemically
and topologically homogeneous nanosheets, with large surface area per unit mass and high
charge density. The stacks of a-ZrP nanosheets are exfoliated with tetrabutyl ammonium
chloride18 to bind metal ions, small molecules, metal complexes and proteins, regardless of their
size.11, 19 , 20 Protein/a-ZrP assemblies, for example, indicated better thermal stability of the
intercalated proteins, and the structure as well as the biological activities of the intercalated
proteins have been retained to a significant extent.13 However, one issue with a-ZrP is that its
affinity for negatively charged proteins is often quite low due to unfavorable charge-charge
interactions with the solid.10 Consistent with this evaluation, we previously noted that conversion
of the anionic proteins to the corresponding cationic-derivatives, via chemical modification of the
surface carboxyl groups to the corresponding amide derivatives, enhanced protein binding
affinities to a-ZrP.21

According to the ICPB model, high affinity binding of anionic proteins to anionic a-ZrP
requires sequestration of appropriate cations at the protein-solid interface to neutralize the
excess negative charge. Therefore, we examined the binding of GOx (isoelectric point, pI, of
4.0.22) and Hb (pI=6.7) to a-ZrP nanodiscs the role of a few metal ions, Zr(IV), Au(III), Cr(III),
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Mg(II), Zn(II), Ni(II), Ca(II), Na(I) and H(I) in the binding mechanism. GOx is chosen for its
importance as a biocatalyst and it catalyzes the conversion of β-D-glucose to δ-gluconolactone
while reducing ambient O2 to H2O2 23,24,25 Hb does not function as an enzyme in nature, but its
role as a peroxidase is well known.26 Both GOx and Hb are negatively charged at neutral pH,27
and their binding to a-ZrP should be influenced by metal ions. The selection of the cations for
the current studies depended on several factors. We chose pH 3 for these studies, since 1 mM
Zr(IV) (pH 3) indicated the highest increases of protein binding to a-ZrP. Au(III), Cr(III), Al(III),
Zn(II), Ni(II) and Cu(II) precipitated these two proteins even at pH 3, while many others were not
soluble in water at pH 3. Systematic variation of charge, size and chemical nature of the metal
ions provided valuable insight into the role of these ions in the binding mechanism.

38

Chapter 2

Introduction

Scheme 2.1. Cation-induced binding of anionic proteins to a-ZrP nanosheets.
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Zr(IV) is strongly oxophilic, thus coordinates readily with the carboxyl groups of aspartate and
glutamate residues of proteins. 28 It binds to the iron-transporter protein 29 , β-casein, 30 the
phosphate groups of a-ZrP,31 and thereby it could potentially function as a metal glue between
the

anionic

proteins

and

the

anionic

a-ZrP

(Scheme

2.1).

Zr(IV)-activated

phosphate/phosphonate surfaces were used to study biomolecular interactions 32 where the
metal mediated the binding.33 Tetravalent Zr(IV) was expected to have greater binding affinity
when compared to trivalent or lower valent metal ions. Many trivalent metal ions could not be
used for the current studies, as these tended to precipitate both proteins even at 1 mM metal
concentration and pH 3. Ca(II) is known to have a higher sorption to a-ZrP over other divalent
metal ions 34 and Ca(II) was expected to bind to the COOH groups of anionic proteins with
moderate to high affinities. 35 Mg(II) also coordinates to certain amino acids and phosphate
groups on proteins, even though much more weakly than Ca(II) or Zr(IV).36

Many divalent and monovalent metal ions have poor coordination abilities for monovalent
ligands, but they have better affinities for poly acids and polyamines due to the chelate effect.37
Generally, protein surfaces have numerous carboxyl and amino groups, which are appropriate
for the coordination of metal ions. Na(I) and H(I) are selected as the monovalent ions for our
studies, and H(I) is required to adjust the pH to 3 to solubilize the above metal salts. Na(I) is
commonly used in many buffers and served as a good control to compare with H(I). Zr(IV),
Cr(III), Ca(II), Mg(II), H(I) and Na(I) provided a simple series to test the role of metal ions on
protein binding to a-ZrP. It is not obvious how the charge or the coordination abilities of metal
ions promote or even inhibit protein binding, and it is not clear how metal-mediation would
depend on the nature of the protein. For example, metal ions can enhance binding due to
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neutralization of a-ZrP negative charge, or they could inhibit binding due to increased ionic
strength or by competing for the phosphate groups of a-ZrP. Therefore, it is not obvious how
these opposing contributions depend on the nature metal ions, metal concentration and nature
of the protein. Here, we clearly establish a method to enhance protein binding using metal ions
and clearly demonstrate that the nature of the metal ion (oxophilicity and phosphophilicitiy) plays
an important role in protein binding. The metal behavior did not depend solely on its charge,
size or coordination behavior, and could not be predicted a priori. Conceptually, both oxophilicity
as well as the phosphophilicty of the metal ion determine its ability to promote protein binding.
Thus, current studies are justified to evaluate these important aspects.

Our data show that metal ions play a major role in protein binding to a-ZrP, in support of
ICPB mechanism. Zr(IV) turned out to be the best metal glue for both proteins, while Ca(II)
promoted the binding of GOx much better than that of Hb.

Thus, binding enhancement

depended on both the metal ion as well as the isoelectric point of the protein.
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2.3. Materials & Methods

2.3.1. Materials. Glucose oxidase (GOx, Aspergillus niger, 90%) and peroxidase type 1 from
horseradish (HRP; specific activity of 356 U/mg) purchased from Calzyme laboratories Inc. (San
Luis Obispo, CA) was used without further purification. Bovine met-hemoglobin (Hb), glucose,
guaiacol, ZrOCl2 and all metal chlorides were purchased from Sigma-Aldrich Co (St. Louis, MO).
Carbon coated TEM grids were purchased from Ted Pella Inc.

2.3.2. Synthesis of a-ZrP. Synthesis and characterization of a-ZrP were performed according
to the previously reported method.16,10 In brief, a-ZrP was prepared by mixing Zr(IV)OCl2
solution with phosphoric acid (9 M) followed by heating at 70 ˚C for 24 h. The resulting white
crystalline solid was filtered, washed with acetone and dried. X-ray powder diffraction data
showed crystalline material with layer spacing of 7.6 Å.

2.3.3. Exfoliation and Enzyme intercalation. Stacks of a-ZrP plates were exfoliated using
tetrabutyl ammonium (TBA) 38 and the nanodiscs were exposed to desired enzyme-metal
solutions at pH 3, which ultimately resulted in the formation of enzyme/metal/a-ZrP intercalates.
The layer spacing increased when enzymes were intercalated in a-ZrP, as monitored by powder
X-ray diffraction. The layer spacing increased from 7.6 Å for a-ZrP to 16 Å for TBA/a-ZrP and
these further increased to ~60 Å when GOx or Hb are bound to the solid in the presence of 1
mM Zr(IV). In the case of Hb, we observed the second order diffraction peak at 31 Å, and this
value is consistent with the layer spacing reported earlier for Hb/a-ZrP of 64 Å.

2.3.4. Binding studies. Protein binding to exfoliated a-ZrP nanodiscs was determined in the
absence or the presence of specific metal ions at constant concentration of metal ion (1 mM)
and a-ZrP (3 mM), but at increasing concentrations of the protein. The concentration of metal-
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ion, was chosen such that there is substantial binding of the protein to the solid but the protein
remained in solution.

In other words, the metal did not precipitate the protein, under our

experimental conditions.

Since the pH of ZrOCl2 (1 mM) solution was 3, we chose this pH in control studies (H(I)) to
account for the pH effect (pH adjusted using dilute HCl). Metal ion, protein and a-ZrP mixtures
were equilibrated for 30 minutes and centrifuged at 10000 rpm for 5 minutes in a Fisher
Scientific microfuge, Acspin micro 17 to separate the free enzyme from the bound.
Concentration of free protein in the supernatant was determined by monitoring GOx absorbance
at 280 nm using the corresponding extinction coefficients (Ԑ
absorbance at 406 nm (Ԑ = 3.397 x 10

5

= 1.336 x 105 M-1cm-1) or Hb

M-1cm-1). Binding isotherms were constructed from

these data and analyzed using Scatchard equation (1). 39 In equation 1, Kb, n, r, cf are the
binding constant, the number of binding sites, binding density (ratio of the concentration of the
bound enzyme to the concentration of a-ZrP) and concentration of free enzyme, respectively.
Scatchard model is designed to quantify the interaction of an identical set of ligands to noninteracting, identical, non-overlapping binding sites on a protein. This single-set of identical
binding sites model is often used as a simplistic model to examine the binding of proteins to
solid surfaces, and any deviations from the model is indicated by poor fits of the data to
equation 1.

Best fits to the data by non-linear least squares analysis resulted in the

corresponding binding parameters.

All conditions for the binding studies with specific metal

ions are collected in Table 2.1.

r/cf = kb (n-r) ---------------(1)
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2.3.5. Zeta Potential studies. Laser Doppler Velocimetry was used to measure the zeta
potentials on a Brookhaven Zeta Plus zeta potential analyzer. Sample suspensions (1.5 ml, 3
mM a-ZrP) in deionized water are prepared and pH adjusted to 3.0 using dilute HCl. The
sample was transferred to a 4 mL polystyrene cuvette (Fisher Scientific). The zeta potential
values were obtained by the Smoluchowski fit by software supplied by the manufacturer and
zeta potentials were calculated from the corresponding electrophoretic mobilities of the
samples. Samples were equilibrated with the appropriate amounts of the metal salt, protein and
exfoliated a-ZrP for 30 minutes at 25˚ C, prior to the measurements.

2.3.6. Activity studies. Activities were measured by suitable modification of published
protocols, and activities of the ternary complexes have been compared with those of the
corresponding binary complexes as well as untreated enzymes, under similar conditions of
buffer, temperature, pH and ionic strength. The enzyme/metal/a-ZrP complexes were resuspended in 10 mM Tris HCl buffer pH 7.0 for activity studies at 25 ˚C. In a typical GOx
assay,40 2-methoxyphenol (10 mM) HRP (2 µM) glucose (0,2 mM) and GOx (1 µM) were used.
The hydrogen peroxide generated by the reduction of oxygen, coupled with the oxidation of
glucose, reacts with 2-methoxyphenol, catalyzed by HRP, to produce a colored product, which
has an absorption maximum at 470 nm. Kinetic data were plotted using Kaleida Graph (version
3.0), and the initial data points (0-15 s) were used to calculate the initial velocities and specific
activities.

In a typical Hb assay, 2-methoxyphenol (2.5 mM in 10 mM Tris HCl buffer at pH 7.0) and
H2O2 (1.0 mM in DI) were added to Hb (1 µM in 10 mM Tris HCl buffer at pH 7) and product
formation has been monitored, at 470 nm, as a function of time.41 The initial velocities and the
specific activities were calculated from the kinetic curves, as described above.
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2.3.7. Transmission electron microscopy and XRD studies. A carbon-coated Cu grid (400mesh) was treated with plasma (Harrick PDC-32G) and coated with 1 mg/mL BSA solution.
Aliquots of 3 µL of 0.5 mM a-ZrP were incubated on the grid for 1 h to allow particle adhesion.
The grids were dried for 1 h and then moved directly to the microscope for imaging. For the
imaging of enzyme/metal/a-ZrP complexes, 3 µL of mixture was applied where the protein
concentration was 0.2 mg/mL and metal was 10 µM. All the imaging has been done with FEI
Tecnai™ Spirit TEM with an operating voltage of 80 kV. The micrographs were recorded in a 4
Mega Pixel AMT camera and presented as they are. The size bars for representative structures
were drawn for clarity.

Suspensions of Protein/Zr(IV)/a-ZrP (2 mL) were spotted on glass slides and air-dried. XRD
analysis of the samples was carried out with a Scintag Model 2000 diffractometer using nickelfiltered CuKR radiation. Scan rates for these runs were 2°/min. The interlayer distances were
measured from the 00l reflections ((l ) 1, 2, etc.,) using Bragg’s law.

2.3.8. Circular dichroism (CD) studies. The CD spectra were recorded on a Jasco J-710 CD
spectrometer using 1 µM GOx or 2 µM Hb, 0.05 or 0.1 cm path length quartz cuvette from 260190 nm, and 1 cm cuvette has been used for recording the Soret CD spectra from 380-450 nm.
Other operating parameters were: sensitivity 20 mdeg, bandwidth 1.0 nm, response time 4 sec,
resolution 0.5 nm, speed 50 nm/min and average of 3 scans. The CD spectra were corrected
by subtracting the buffer signal, and data have been normalized as ellipticity per micromolar
enzyme per unit path length.
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2.4. Results

In simple terms, the assembly of negatively charged proteins on a negatively charged solid is
feasible when excess negative charge at the protein-solid junction is neutralized by the
sequestration of appropriate metal ions (Scheme 2.1). Explicit binding studies are carried out
here to test this mechanistic model, using particular metal ions. Among the cations used here,
Zr(IV) is the most acidic, 1 mM solution in water had pH 3, and hence, binding studies with all
other metal ions were carried out at pH 3. Details of our studies are enumerated below.

2.4.1. Effect of Zr(IV) on protein binding. The stacks of a-ZrP were exfoliated by exposure to
stoichiometric amounts of tetrabutyl ammonium hydroxide (TBA) and exposed to appropriate
enzyme/metal ion mixtures (Scheme 2.1).

The metal ion concentrations and protein

concentrations were chosen such that the proteins did not precipitate in the presence of the
added metal ion. At each metal ion concentration, bound protein concentration has been
determined in centrifugation studies (Figure 2.1).

GOx did not bind to a-ZrP substantially, in the absence of Zr(IV), and binding increased from
~ 5% to ~90% at 0-1.0 mM [Zr(IV)] (Figure 2.1.A). Further addition of the metal had no effect
on binding, and after centrifugation of the samples, the GOx/Zr(IV)/a-ZrP appeared as yellow
precipitates (inset in Figure 2.1.A). In the absence of a-ZrP, the metal did not precipitate the
protein, under any of these conditions.
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A.

B.

Figure 2.1 (A) Binding of GOx (20 μM) and Hb (50 µM) to a-ZrP (3 mM) as a function of the
added Zr(IV) ion concentration (0 to 1.5 mM) in DI water, at room temperature. The color of aZrP changed from white to light yellow due to the binding of GOx, after centrifugation, as
indicated in the inset photograph. (B) Enhanced binding of Hb to a-ZrP by Zr(IV) and binding
inhibition at higher concentrations. The color change of the supernatant accompanying Hb
binding is shown in the inset picture. Error bars on some points are too small to be visible.
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Encouraged by the above findings, we tested if this strategy would also enhance the binding
of moderately negatively charged Hb (pI 6.7). Hb (80 µM) binding to a-ZrP (3 mM) increased
from ~85 to 100% by the addition of Zr(IV) (0-0.5 mM) and reached a plateau (1 mM Zr(IV)) and
further addition (> 1 mM) inhibited Hb binding altogether (Figure 2.1.B).

Under these

conditions, Zr(IV) did not precipitate Hb, and binding inhibition above 1m M Zr(IV) is not due to
Hb precipitation. Zr(IV) may compete and displace Hb from the surface. The colors of the
supernatants of Hb/Zr(IV)/a-ZrP mixtures after centrifugation, as a function of increasing Zr(IV)
concentration, are shown in inset in Figure 2.1.B. Hb binding to a-ZrP was also promoted by
Zr(IV), not as dramatically as with GOx because of the high affinity of Hb in the absence of
Zr(IV), and binding saturated at 100%, even at high protein concentration (80 µM) and low metal
ion concentration (0.5 mM).

2.4.2. Effect of other metal ions on the binding affinities. Encouraged by the facile, Zr(IV)mediated, binding of both GOx and Hb to a-ZrP, next we tested if this metal-promoted binding is
unique to Zr(IV). The binding of GOx (20 µM) to a-ZrP (3 mM) was monitored in the presence
of Cr(III), Ca(II), Mg(II), Na(I) and H(I) (1 mM cations, pH 3) and compared the data with that of
Zr(IV)-mediated binding (Figure 2.2, right bars). Ca(II) improved GOx binding substantially
(~70%), slightly less than that of Zr(IV) (80%), but much better than Cr(III) (~35%), Mg(II)
improved GOx binding by ~30%, while Na(I) had essentially no measurable effect.
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Figure 2.2. Binding of GOx (20 µM) and Hb (80 µM) to a-ZrP (3 mM) as a function of specific
metal ions (1 mM, pH 3), as marked. Data in the absence of added metal ion were obtained at
pH 7, and Cr(III) data are corrected for a small amount of protein precipitation by the metal ion.
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H(I) (pH 3) improved GOx binding marginally (10%) but it was much better than that by
Na(I) and highlights the weak role of pH in GOx binding to a-ZrP. The role of H(I) depends on
the pKa values of the specific functional groups at the interface, protonation and deprotonation,
while the role of Na(I) depends on its binding/dissociation at the interface. H(I) and Na(I), having
the same charge, served to evaluate specific roles of these ions in the binding process. Au(III),
Al(III), Zn(II), Cu(II) and Ni(II) precipitated the protein even at pH 3, and could not be used for
binding studies. The metal-mediated GOx binding (1 mM metal ion, pH 3) followed the trend,
Zr(IV) > Ca(II) >> Cr(III) > Mg(II) >> H(I) > Na(I), which indicated that the metal ion charge is not
the absolute criterion to predict the ability of metal ions to promote protein binding.

Intrigued by the above unexpected trend, we examined the role of the protein by replacing
strongly anionic GOx by a more moderately anionic Hb. Hb (80 µM) binding to a-ZrP (3 mM, pH
3) was also influenced by metal ions and the corresponding binding data are shown in Figure
2.2 (left bars) for comparison with those of the corresponding GOx data.

One major difference between GOx and Hb is that Hb binds to a-ZrP with moderate affinity
(56% binding, 80 µM Hb, 3 mM a-ZrP, pH 7), even in the absence of added metal ions (Figure
2.2). However, the binding was essentially quantitative (97%) in the presence of 1 mM Zr(IV).
When compared to data in Figure 2.1, the Hb concentration in this experiment was increased to
80 µM, so that there will be a substantial amount of free protein available for metal-promoted
binding. Zr(IV) enhanced the loading capacity of Hb to 1:38 (protein to phosphate) mole ratio or
400% w/w.

Such high loadings of proteins are rare to achieve and high loadings of the

biocatalyst are advantageous for catalytic applications.

The next best promoter of Hb binding among all ions tested here was H(I), and this is
primarily because Hb is strongly positively charged at pH 3 (pI 7). Hb affinity improved at pH 3
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(75%) when compared to binding at pH 7 (56%), while all cations, except Zr(IV), did not exceed
the effect of H(I), and Hb binding followed the order Zr(IV) > H(I) > Mg(II) > Na(I) > Ca(II) >
Cr(III).

Thus, H(I) is more effective than the trivalent Cr(III), which suggests that charge is not

the primary criterion. Ca(II), which promoted the binding of GOx strongly, had no such effect on
Hb. Thus, the metal ion effect on the binding depended on the protein as well as the metal ion.

2.4.3. Effect of Protein concentration on binding. Improved binding of both GOx and Hb to aZrP by added metal ions prompted us to quantify the binding constants. Binding studies were
carried out at constant metal (1 mM) and a–ZrP (3 mM) concentrations, while varying the
protein concentration at pH 3 (Figure 2.3).
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A.

B.

Figure 2.3. Binding isotherms of GOx (A) and Hb (B), per cent bound protein as a function of
total protein concentration at a constant Zr(IV) (blue curves), Ca(II) (green curves) and H(I) (red
curves) concentration (1 mM) and constant a-ZrP (3 mM) at pH 3.
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In the presence of Zr(IV) and Ca(II), as observed above, GOx exhibited high per cent of
binding and nearly 90% binding has been achieved at low GOx concentration (10 µM) and 1
mM Zr(IV) (Figure 2.3.A, blue triangles). Even at the highest GOx concentration (60 µM) 58%
of GOx was still bound, or 100% w/w (GOx to a-ZrP), and the amount of bound protein
increased steadily with increase in protein concentration. These data were compared with the
isotherms obtained in the presence of Ca(II) (green triangles) and H(I) (blue triangles, (Figure
2.4.A). Isotherms for Ca(II) and Zr(IV)-mediated GOx binding are nearly the same, but these
indicated higher loading than that of H(I).

The binding isotherm with Mg(II) indicated a similar effect as H(I) (Figure 2.4.B, black
triangles), but Na(I) had essentially no effect (green triangles). Binding isotherms with Cr(III)
could not be obtained because of extensive protein precipitation by Cr(III) at > 20 µM GOx.

We also quantified the binding of Hb to a-ZrP in the presence of Zr(IV) to construct the
corresponding binding isotherms, and the data are shown in Figure 2.3.B. Nearly 100% of Hb
was bound in the presence of Zr(IV) (1 mM), a-ZrP (3 mM), and this continued up until 80 µM
Hb and then the percent binding began to decrease (100 µM Hb). Highest loading of Hb (80 µM
Hb, 400% w/w Hb to a-ZrP) was obtained with Zr(IV), which is nearly twice as much as that of
Ca(II) but better than that with H(I).

The binding isotherms of Hb depended on the type of cation used (Figure 2.4.B), as in the
case of GOx. At low Hb concentrations, all cations promoted binding substantially (~100%),
nearly equally, but the differences are clearer at higher Hb concentrations. At 80 µM Hb, for
example, the order of binding was Zr(IV) > H(I) > Mg(II) > Na(I) > Ca(II), where Zr(IV) nearly
doubled Hb loading on a-ZrP.
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A.

B.

Figure 2.4. Effect of protein concentration in binding for different metal ions and pH 3. Extent of
binding against protein concentration in the presence of xpecific metal ions. A. GOx/metal/a-ZrP
data shows that Zr(IV) increased the affinity of GOx the largest, when compared to any other
system. B. Hb/metal/a-ZrP binding data which shows that after certain concentrations lead to
maximum loading. Studies done with 1 mM metal concentration in DI water. Data at pH 7
(protein/α-ZrP) were shown for comparison.
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2.4.4. Binding constants. The above data was analyzed using the single, identical binding site
model (Scatchard analysis), and the corresponding binding plots have been obtained for GOx
and Hb with Zr(IV), Ca(II) and H(I) (Figure 2.5). The Scatchard plot of GOx obtained in the
presence of 1 mM Zr(IV) was linear (Figure 2.5.A), and the best fit to equation 1 yielded a Kb of
5.4 x 105 M-1 and a binding site size of 140 phosphates per GOx. Six data points were used to
calculate the binding constant and the R value is 0.95. Almost the same results were obtained
for Ca(II) with a binding constant of 5.1 x 105 M-1. In the absence of Zr(IV), the binding of GOx
was too weak to obtain a good Scatchard plot, but the best estimate was 0.014x105 M-1 (pH 3).
GOx binding affinity was enhanced ~380-fold by both Zr(IV) and Ca(II) (1 mM). The binding of a
large ligand such as a protein with a solid surface involves, multi-point vs multi-point binding,
and the Scatchard analysis is too simplistic a model. Scatchard model appears to be valid here,
as indicated from the above reasonable linear fits to equation 1 in Figure 2.5, and validity of
such analysis can be understood in terms of the assumption that the protein functions as a
single binding domain and that the entire binding site on the solid functions as a single integral
binding site. This simplistic treatment is not unique to the current systems and it has been
widely noted ealier.11-15
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B.

Figure 2.5. Scatchard plots in the presence of Zr(IV) (1 mM) (blue triangles), Ca(II) (green
triangles) and H(I) (red triangles) for the binding of (A) GOx and (B) Hb to a-ZrP (3 mM, pH 3).
The error bars on some points are too small to be visible.

56

Chapter 2

Results

In contrast to the high affinity binding of GOx, the binding constant of Hb increased only ~
40-fold from 1.08 x 105 M-1 (H(I)) to 4.7 x 106 M-1 by Zr(IV) (Figure 2.5.B), and the number of
phosphates occupied per Hb decreased from ~50 to ~35, thus enhancing the affinity and
capacity. In case of Hb binding data, 6 data points were used to calculate the binding constants
and R value was 0.88. Ca(II) did not have any effect on the binding constant of Hb, nearly the
same as that with H(I) (Figure 2.6) The binding plots with other metal ions were also obtained
(Table 2.1) and the binding constants varied in the order Zr(IV) >> Mg(II) > Na(I) > Ca(II) > H(I)
while the binding site sizes (n) varied from 35 to 60 phosphates per Hb. The maximal loading of
Hb (400%) was nearly twice as that observed with GOx (200%). 3

Table 2.1: Binding constants and number of phosphate groups coordinated per protein Values
obtained from Figure 2.6:

Some systems did not fit well and the corresponding binding

constants were not estimated.

System
GOx/Zr(IV)/ a-ZrP
GOx/Ca(II)/Z a-ZrP
GOx/ a-ZrP
Hb/Zr(IV)/ a-ZrP
Hb/Ca(II)/ a-ZrP
Hb/Mg(II)/ a-ZrP
Hb/Na(I)/ a-ZrP
Hb/ a-ZrP @pH 3
Hb/ a-ZrP

Binding constant
Kb (105 /M-1)
5.4
5.1
0.014
46.9
7.1
24.5
11.2
6.6
1.0
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Number of
phosphate
groups, n
140
145
412
35
73
56
60
47
50

Maximum
Loading(w/w %)
Protein to a-ZrP
100
100
40
400
220
250
240
300
200
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Figure 2.6: Schatchard Plots of specific enzyme/metal/a-ZrP systems. The pH was 3.0 in all
cases except for the ones denoted as GOx/a-ZrP and Hb/α-ZrP (pH ~6.0). Binding constants
and number of phosphate groups occupied was calculated and given in Table 2.1.
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2.4.5. Zeta Potential Studies. The above data indicated the strong role of metal ions in protein
binding to a-ZrP, and we examined metal binding to a-ZrP nanosheets by zeta potential
measurements, which provides the average charge of the suspended particles. The binding of
metal ions to a-ZrP nanosheets is expected to lower its negative charge, and hence, zeta
potential would be a direct measure of metal binding to the phosphate groups of the a-ZrP
nanosheets (phosphophilicity).

The charge of exfoliated a-ZrP (3 mM) at pH 3 was -42 ± 3 mV, for example, it linearly
increased with the addition of Zr(IV), reached zero at 0.4 mM Zr(IV) and further addition
increased to +45 ± 4 mV at 1 mM Zr(IV), Figure 2.7.A). This charge variation and charge
reversal is a direct evidence of Zr(IV) binding to a-ZrP nanosheets, even at these low mM
concentrations of Zr(IV). Zeta potential measurements, therefore, were used to compare the
relative affinities of specific metal ions (1 mM) to a-ZrP (Figure 2.7.B) where some metal ions
are much more effective in lowering its negative charge or imparting it a net positive charge.
The net charge on a-ZrP nanosheets followed the order, Zr(IV) >> Cr(III) > Zn(II) > Ni(II) >
Mg(II) > Ca(II) > Au(III) > Na(I), a direct measure of the relative phosphophilicities of these metal
ions. Despite the high charge, Au(III) is a poor binder to a-ZrP, while Cr(III) is much better than
all other metal ions, except Zr(IV). The divalent metal ions differed substantially, in terms of
their affinities for a-ZrP and Zn(II) showed the highest affinity while Ca(II) had the lowest. Thus,
metal binding to a-ZrP cannot be predicted solely based on metal ion charge.
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Figure 2.7. Zeta potential of exfoliated a-ZrP nanosheets (A) as a function of [Zr(IV)] at pH 3,
and (B) as a function of specific metal ions (1 mM) at pH 3.0, 25˚ C.
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Zeta potential measurements were also useful to follow the binding of proteins to a-ZrP
(Figure 2.8.A & B). The gradual addition of GOx (up to 6 µM GOx) to a mixture of Zr(IV) (1 mM)
and a-ZrP (3 mM, pH 3) decreased the charge from 45 ± 4 mV to +20 ± 4, and then there was
no significant change with further increase in protein concentration. In the case of Hb, charge
decreased almost linearly with protein concentration from + 45 ± 4 to +16.0 ± 4 mV (Figure
2.8.B).

The charges on specific protein/metal/a-ZrP complexes were also compared (Figure 2.8.C),
and zeta potentials followed the order, Zr(IV)/ a-ZrP > GOx/Zr(IV)/ a-ZrP > Hb/Zr(IV)/ a-ZrP >
Hb/a-ZrP > GOx/a-ZrP > a-ZrP. The metal/protein/a-ZrP complexes had a net positive charge,
lower than that of Zr(IV)/ a-ZrP, which indicated charge neutralization by protein binding; while
the protein/a-ZrP complexes had a net negative charge, lower than that of a-ZrP, which also
indicated charge neutralization by protein binding. We observe that there was an average drop
of +20 mV after protein binding to metal/a-ZrP, and an average drop of -25 mV of charge due to
protein binding to a-ZrP. Both these opposing observations indicate charge reduction, which
can be explained only if ions are released or absorbed during protein binding.
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B

D

Figure 2.8. Variation of zeta potential by the addition of 2 µM increments of GOx in (A) and 10
µM increments of Hb (B) to Zr(IV) activated a-ZrP; (C) Zeta Potential of intercalated systems at
binding saturation. a-ZrP, Zr(IV) bound to a-ZrP, GOx/Zr(IV)/ a-ZrP, GOx/a-ZrP, Hb/Zr(IV)/ aZrP and Hb/a-ZrP, 3 mM a-ZrP, 1 mM Zr(IV) , 20 µM GOx and 80 µM Hb were used here. All
analysis has done in DI water at pH 3.0. (D) Efficiency of Anionic protein (GOx) binding plotted
against charge on a-ZrP layers (3 mM). Surface charge of the nanolayer was modulated using
different metal ions (1 mM) as noted in the plot.
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2.4.6. TEM studies. Morphology studies were carried out to confirm the assembly of GOx in aZrP galleries in the presence of Zr(IV). The micrographs of exfoliated a-ZrP showed nanosheets
of 200-300 nm in size (Figure 2.9) while GOx/Zr(IV)/ a-ZrP (Figure 2.9.B) formed elongated,
uniform stacks of several micrometers in length, which is quite surprising.

Previously, powder XRD studies showed that exfoliated a-ZrP plates re-assemble back to
the layered structure after enzyme binding.19 But the neat, ordered arrangement was rarely
seen in the TEMs or SEMs after protein intercalation.

The formation of long strands of

metal/enzyme/inorganic strands of over a micron length and about half a micron in diameter are
novel features of these materials.

The powder XRD also confirmed the TBA/a-ZrP stacks (a sharp peak at 16.9 Å)
(Supplementary Materials, Figure

2.10, as reported earlier.19 Layered structures of

protein/Zr(IV)/ a-ZrP are observed. The TEM data, combined with the powder XRD, confirm
that proteins intercalate between the layers of a-ZrP, and these appear to form large selfassembled structures.
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Figure 2.9. TEM images of exfoliated a-ZrP (A) and GOx/Zr(IV)/a-ZrP (0.2 mg/mL GOx, 0.01
mM Zr(IV), 0.5 mM a-ZrP) (B) indicated the layered structures of the metal enzyme assemblies
in a-ZrP on a micrometer scale.
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Figure 2.10. XRD of Metal/ enzyme–a-ZrP films showing the difference in spacing. Exfoliated αZrP showed a d value of 16 Å. Hb/Zr(IV)/ a-ZrP showed 31 Å and Go/Zr(IV)/ a-ZrP showed a
broad peak around 51 Å. Hb/Zr(IV)/ a-ZrP data is multiplied by factor of 10 and normalized. Hb
has average radius around 60 Å. So we assume that the diffraction is second order.
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2.4.7. Enzyme structure retention and activities of the bound enzymes. One very important
aspect of a biocatalyst is that it should have substantial structure retention and activity. Circular
dichroism (CD) studies are used to examine the extent of retention of protein structure in the
above assemblies. The far UV CD spectra of the samples are recorded in the 190-260 nm
region and compared with those of free proteins Data showed that the CD spectra of GOx and
Hb are distorted to some extent by the metal ions but this distortion is relieved in the case of
Cr(III), on binding to a-ZrP (Figure 2.11).
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Figure 2.11. Circular dichroism spectra show that the protein secondary structure is conserved
after intercalation to a significant extent. A & C; CD spectra of intercalated GOx and Hb
respectively. We find that when the intercalation is strong the intensity got reduced. B & D; Data
for GOx and Hb in presence of metal ions shows the effect of metal ions on protein secondary
structure. E & F; Soret band CD spectra of Hb after intercalation and in the presence of metal
ions respectively. All analysis was done in 10 mM Tris-HCl at pH 7.0 and 25oC.
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The loss of structure was a concern and we examined this aspect by quantitating the oxidase
and peroxidase activities of the bound GOx and Hb, respectively. The GOx/metal/a-ZrP
biocatalysts are suspended in phosphate buffer, and kinetic traces are followed as a function of
time. The initial rates of the reaction are obtained from the slopes of the kinetic plots at early
times, and the corresponding specific activities shown in Figure 2.12.

Specific activities of GOx and Hb samples are normalized with respect to that of free GOx
and Hb as 100% respectively.

The relative activities of the GOx/metal (brown bars) or

GOx/metal/a-ZrP (blue bars) varied from 70-100% (Figure 2.12). Zr(IV), Cr(III), Mg(II) and
Ca(II) did not have substantial effect on GOx activity, and all GOx/metal/solid assemblies had
nearly same specific activities. The specific activity of GOx/Zr(IV)/ a-ZrP (6.1 x 10-3 M-1 s-1) is
essentially the same as GOx/H(I)/ a-ZrP (5.7 x 10-3 M-1 s-1, under the same conditions). While
metal ions have increased affinities and improved loadings, they did not adversely influence
GOx activities.

Along these lines, specific activities of Hb/metal/a-ZrP (green bars) and Hb/metal (black
bars) are compared under the same conditions (Figure 2.12). Hb/Zr(IV)/ a-ZrP activity (3.6 x 104

M-1 s-1) is slightly lower than that of Hb/H(I)/ a-ZrP (5.4 x 10-4 M-1 s-1). Activities of Hb/metal/a-

ZrP followed the order H(I) > Na(I) >Mg(II) > Cr(III) > Ca(II) ~ Zr(IV).
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Figure 2.12. Comparison of the percent retention of enzyme activities for GOx (1 µM) bound to
a-ZrP (0.2 mM), 0.1 mM metal in 10 mM Tris-HCl buffer at pH 7.0 at room temperature, and Hb
(1 µM) bound to a-ZrP (0.06 mM) in 10 mM Tris-HCl buffer at pH 7.0 at room temperature. The
kinetic traces of the activity assays (Absorbance v/s time) for different systems are used to
determine the initial rates and specific activities.
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2.5. Discussion

The role of metal ions in the binding of proteins to a-ZrP nanodiscs is tested here, and the
binding resulted in protein intercalation into the galleries. The binding, morphology, structure
and activities indicated that Zr(IV) and Ca(II) functioned as excellent metal glues to enhance
protein binding and loading. Ca(II) increased the binding affinity of GOx but not that of Hb.
These observations are consistent with the proposed ICPB mechanism for the binding of
anionic proteins to anionic a-ZrP.

GOx is negatively charged at neutral pH (pI ~4),27 and its affinity for the negatively charged
α-ZrP is poor even at pH 3. According to the ICPB mechanism, sequestration of appropriate
cations at the protein-solid interface facilitates binding by promoting charge neutralization at the
interface. Current data show that 1 mM Zr(IV) and Ca(II) essentially increase GOx binding (20
µM GOx) to a-ZrP (3 mM, pH 3) from essentially zero to 90%, and enhancements depended on
the protein concentration as well as the metal concentration. Increased affinity was not at the
expense of activities, as indicated by the activity studies. The affinity increases depended on the
type of metal ion as well as the nature of the protein. Metal ions that bind tightly to the solid as
well as the protein are expected to be the best metal glues. Zeta potential studies indicated the
relative affinities of the metal ions for the nanosheets followed the trend, Zr(IV) >> Cr(III) > Zn(II)
> Ni(II) > Mg(II) > Ca(II) > Au(III) > Na(I) > H(I) which is related to their relative phosphohilicities.
Zr(IV) is strongly oxophilic and its high affinity for the phosphate groups of α-ZrP has been
already demonstrated,28,29,30,31 and current data are consistent with these reports.

Quantitative binding of Zr(IV) to exfoliated nanosheets of α-ZrP was confirmed by the
phenylphosphonic acid chelation assay. The amount of free [Zr(IV)] after equilibration with 1 mM
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a-ZrP (pH 3) was determined, after separation by centrifugation followed by chelation with
phenylphosphonic acid. Zr(IV) has high formation constants with carboxylic and amine
ligands,

33,42,43

and strong affinity of Zr(IV) for a-ZrP may be combined with its high affinity for the

carboxylic and/or amino groups of proteins to enhance protein binding to the solid by several
orders of magnitude. The high charge density, large coordination number and high phosphate
affinity of Zr(IV) are responsible for its role as a metal-glue. The Zeta potential data suggest
that Cr(III) is also strongly phosphophilic, next to Zr(IV), but it is surprising that Au(III) had much
poorer ability to neutralize ZrP charge than anticipated.

Ca(II) was known to have a high affinity to a-ZrP over any other divalent cations,

34

but zeta

potential data show that it is not as good as Zn(II), Mg(II) or Ni(II), and this deviation is due to
lower pH used here (pH 3). Ca(II) also improved protein binding much better than Mg(II), and
protein binding studies with Zn(II) and Ni(II) could not be carried out due to precipitation issues.
Note that Ca(II) is a better binder to the COOH/NH2 groups of proteins than Mg(II). Thus,
charge is not the only criterion for predicting the binding enhancement. The ability of the metal
to coordinate to the phosphate groups of the solid and/or to the carboxyl/amino groups of the
proteins is also important in assessing the efficacy of a metal ion in promoting protein binding to
a-ZrP.

Ca(II) promoted GOx binding to a-ZrP but not Hb, but Zr(IV) promoted binding of both
proteins to a-ZrP. Thus, metal-mediated binding depended on the protein. In the case of
Zr(IV), both amino and carboxylic groups are known to coordinate to the metal, and it can
complex with either the COOH-rich surface of GOx or the COOH/NH2-rich surface of Hb or to
the phosphate groups of a-ZrP. Ca(II) may have higher specific affinity for GOx than Hb due to
the larger number of surface COOH groups on GOx (132 per GOx dimer, 1.7 carboxylic
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groups/nm2 of protein surface) when compared to that of Hb (60 COOH groups per tetramer,
0.53 carboxylic groups/nm2 of protein surface and 61 lysines per tetramer, 0.54 amino
groups/nm2 protein surface). The formation constants of amino or poly amino complexes of
Ca(II) are small,

37

but the log K of poly carboxylic ligands with Ca(II) was 3-4 times higher than
37

that with a simple acetate group.

So, we suspect that Ca(II) may bind better to the carboxyl-

rich surfaces of GOx than amine-rich surfaces of Hb.

Mg(II) was more effective in reducing the negative charge of a-ZrP than Ca(II) (more
phosphophilic) but its ability to promote GOx binding to a-ZrP was much less than that of Ca(II),
and significantly less than Mg(II)-mediated binding of DNA to mica.12 Both Mg(II) and Ca(II)
complexes of phosphate and carboxylate ligands have comparable formation constants,

37

but

binding of Mg(II) to proteins is weak.44 To sum up, it is not just the charge of the cation that is
important but its affinity for the functional groups decorating the protein surface as well as the
phosphate groups of a-ZrP play an important role in promoting protein binding.

The average area occupied by GOx at the highest loading is 3500 Å2 as estimated from the
maximum loading of 100% (w/w). This value is comparable to the cross sectional area of GOx
(diameter of ~60 Å).22 It points to a very tight packing of GOx in the galleries, and this could be
one reason that the activity of GOx/Zr(IV)/ a-ZrP is lower than that of the free GOx. Strong
interactions and high loading may have resulted in the formation of metal/enzyme frameworks
which appeared in the TEMs to be neatly arranged. The maximal loading of Hb was much
greater than GOx, 200% (w/w), and this is far greater than reported for any other protein or
solid.

72

Chapter 2

Discussion

In general, the w/w binding capacities of a variety of solid surfaces rarely exceed 50%,45 and
one exception has been the loading of urease on a tentacle type polymer (100% w/w, enzyme
to solid).46 Compared to other supports, a-ZrP is a promising solid platform for high protein
loadings, when used in conjunction with suitable metal ions. This is because of the large
number of phosphate groups per unit area of a-ZrP (1 per ~25 square Å) and charge
neutralization of the enzyme/solid interface may be very important requirement for high loading.
Enhanced binding density is important for biocatalytic applications where maximal loading of the
catalyst per unit mass of the support matrix is beneficial. In support of these inferences, a-ZrP
has been reported to form multilayerd self-assembled structures.17

Formation of long strands

of GOx/Zr(IV)/ a-ZrP with near-perfect ordering of the plates is unusual and this indicates the
propensity for assembly formation.

Enzyme/metal/a-ZrP materials retained significant activities, which are comparable to those of
the corresponding enzyme/a-ZrP binary complexes but less than those of the free enzymes.
The specific activities of GOx/Zr(IV)/a-ZrP and Hb/Zr(IV)/ a-ZrP are 6.1 x 10-3 M-1s-1 and 3.6 x
10-4 M-1s-1, respectively, and these are comparable to those of the corresponding enzyme/a-ZrP
complexes (5.2 x 10-3 M-1s-1 for GOx and 5.4 x 10-4 M-1s-1 for Hb). Zr(IV) and Cr(III) inhibited
specific activities of GOx to a small extent, and this could be partly responsible for the reduction
in the activities of the corresponding GOx/metal/a-ZrP materials. Activities of all GOx/metal/aZrP examined here are comparable to that of GOx/H(I)/ a-ZrP, while activities of Hb/metal/a-ZrP
followed the trend H(I) > Na(I) > Mg(II) > Cr(III) > Ca(II) ~ Zr(IV). Higher affinities for the solid
correlated with lower activities, with the exception of Hb/Na(I)/ a-ZrP. The tight packing of the
proteins in the galleries, promoted by efficient charge neutralization by the added metal ions,
could be one reason. Even so, the metal/enzyme/solid ternary complexes retained substantial
activities, despite crowding in the galleries.
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2.6. Conclusions

Metal ions, protons, counter ions, water molecules and others are to be considered in the
adsorption of proteins on solid surfaces. In particular, previous studies suggested that
sequestration of cations is required to neutralize excess charge that could develop at the
interface when a negatively charged enzyme binds to a negatively charged solid. Sharing of
ions was also suggested when anionic biomolecules such as DNA bind to anionic solids such as
mica where Mg(II) played a key role in charge neutralization. The strength of interaction
depended on the charge density of the biomolecule, the solid and the metal ion.47 Here, we
tested the role of specific cations in the binding of two model systems GOx and Hb. One of the
most exciting observations is that the binding affinities of both proteins are increased
significantly by Zr(IV), primarily due to its strong phosphophilicity for the a-ZrP surface and the
carboxyl/amino surfaces of proteins. Zeta potential data show that Zr(IV) and Cr(III) are far
better binders to a-ZrP than all the other metal ions tested here. Out of these two proteins, GOx
is the highest negatively charged protein (charge > -80 at pH 7, pI = 4, positively charged at pH
3) which showed highest metal-enhanced binding. On the other hand, Hb showed higher
binding in the absence of metal and less metal-mediated binding (pI ~ 6.7). Ca(II) promoted the
binding of GOx but not Hb, because of its moderate affinity for a-ZrP but strong ability to
coordinate to the carboxyl-rich GOx surface but not the amine-rich Hb surface.

The increase in the affinity cannot be attributed to simple ionic strength effects or pH changes,
although these do contribute to binding enhancements. Metal ion binding to the anionic a-ZrP
nanodiscs and to the enzyme surface contributes to the observed affinity increases. The ions
with the highest charge, charge density, oxophilicity and phosphophilicity (Zr(IV), Ca(II), H(I))
promoted the binding the most, while no correlation was noted with ion size, hydration or charge
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density. The proposition that cations may play a key role in the binding of these systems with aZrP is confirmed, and for a given metal, the extent of affinity increase depended directly on
enzyme charge.

Consistent with this evaluation, we previously reported that when these anionic proteins are
converted to the corresponding cationic derivatives by surface group modification, their binding
affinities to a-ZrP was increased by orders of magnitude.21 Thus, these two approaches are
parallel, complementary and confirm the strong role of charge in the binding interactions.

High affinities are also accompanied by higher loading capacities and this aspect is promising
for biocatalytic applications, and suitable cations can enhance loading as well as binding
affinities without compromising activities. To the best of our knowledge, the maximum loading
of 400% w/w of any protein on any solid is the highest ever reported, and nearly 400-fold
increase in binding affinity of GOx is also novel. Our conclusion is that metal ions provide new
avenues to enhance binding of anionic proteins to anionic solids, when there are suitable
functional groups on one or both partners for anchoring the cations.

TEM images show that the structure of the solid after immobilization is also conserved, and that
metal ions promote the self assembly of proteins and a-ZrP nanosheets as long strands.
Proteins generally do not tend to self-assemble, unless the unfavorable protein-protein
repulsions are overcome by suitable means. Metal ions of appropriate charge density and solid
surfaces serve to control these interactions and form macroscopic frameworks.

In addition to the effect on the binding, the metal ions also influenced the catalytic activities of
the bound enzymes. This was not anticipated. Far UV CD data showed that the CD spectra of
GOx and Hb are distorted but this distortion is relieved to some extent, in the case of Cr(III), on
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binding to a-ZrP (Figure 2.11). In the case of Zr(IV) the protein structure is distorted to a large
extent but appreciable amount of activity is still retained and bound enzyme activities are
comparable to those of the native enzymes. We conclude that carefully chosen cations can
enhance the binding affinities of particular proteins by orders of magnitude without adversely
affecting their activities, and this ability depends on their affinities for the solid as well as the
proteins. These physical insights are important in the rational design of surfaces for benign,
high affinity adsorption of proteins to solid surfaces.
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Abstract

Tuning Biological Activity of Graphene Oxide by Biophilization
approaches
3.1 Abstract
Graphene oxide (GO) is being extensively investigated for enzyme and protein binding, but
many enzymes bound to GO denature considerably and lose most of their activities. A simple,
novel and efficient approach is described here for improving the structures and activities of
enzymes bound to GO such that bound enzymes are nearly as active as those of the
corresponding unbound enzymes. Our strategy is to pre-adsorb highly cationized bovine serum
albumin (cBSA) to passivate GO, and cBSA/GO (bGO) served as an excellent platform for
enzyme binding. The binding of met-hemoglobin, Glucose oxidase, Horseradish Peroxidase,
BSA, Catalase, lysozyme and Cytochrome c indicated improved binding, structure retention and
activities. Nearly 100% of native-like structures of all the 7 proteins/enzymes were noted at
near monolayer formation of cBSA on GO (400% w/w) and all bound enzymes indicated 100%
retention of their activities. A facile, benign, simple and general method has been developed for
the biophilization of GO and this approach of coating with suitable protein-glues expands the
utility of GO as an advanced biophilic nano material for applications in catalysis, sensing and
biomedicine.
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3.2. Introduction

Graphene and graphene oxide (GO) are emerging as excellent materials for practical
applications due to their remarkable mechanical, electrical and optoelectronic properties. 1 A
general, facile, simple approach for biophilization of GO (bGO) is reported here, and enzymes
bound to bGO indicated structures/activities that are nearly the same as those of unbound
enzymes. Graphene is considered as a new generation nanoelectronic material because of its
high carrier mobility, room temperature quantum hall effect and others. 2 These properties
ensure graphene as a promising candidate for the fabrication of advanced devices such as field
effect transistors (FETs), supercapacitors, solar cells, etc.1,
biocatalysis,5,6,7 biosensors,8,9 bioelectronics8 ,and biomedicine

3 , 4

10,11,12

Application of GO in

is highly promising. The

nanosheets of GO (surface area = 7.05 x 1022 Å2/g)5 are decorated with COOH, OH, epoxide
groups and hydrophobic patches that enabled adsorption of biomolecules. 13 , 14 , 15 So far,
functionalization of GO with amines,16 proteins,17 chemical reduction,18 and PEGylation,10 were
used to improve the nature or affinity of GO for biomolecules.

Despite these efforts, enzyme binding to GO often results in significant loss of structure
and/or function, which is not desirable. Horseradish peroxidase (HRP) and esterase bound to
GO, for example, lost ~70% of their activities.5,18 But in the case of lipase and oxalate oxidase,
the activities were improved due to extensive distortion of bound protein.18 The biomolecule-GO
interactions often result in significant loss of biomolecular structure cited as a fundamental
problem.18,19 These interactions are not well-understood,18 and reports suggest that they are
primarily hydrophobic and/or electrostatic in nature.18,19, 20 Systematic manipulation of these
interactions under chemical or biochemical control will be central for the rapid development of
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biological applications of GO, as well as in assessing, predicting and controlling the biological
toxicity of GO.

We have previously investigated the molecular details of enzyme binding to inorganic
layered solids and developed specific strategies to control these interactions.21 Highly hydrated
and strongly polar or ionic surfaces provide a benign environment for favorable binding of
biomolecules,22,23 and the hydration layer on the host surface promotes the retention of bound
enzyme structure and activity to a significant extent. These strategies are now being extended
to control enzyme-GO interactions in a predictable manner.

Our hypothesis is that the

conversion of hydrophobic regions of GO into highly hydrated and hydrophilic, charged regions
would support favorable interactions with biological molecules and enhance the retention of their
structures and activities.

This hypothesis is tested here by adsorbing a protein glue on GO such that the glue
provides a suitable, hydrated, chemically controllable surface for enzyme binding. Choice of
this biophilic glue is important and while it should bind tightly to GO it also should enhance the
binding of a variety of enzymes and proteins.

The glue should convert the hydrophobic,

unfavorable GO surface regions into a benign environment for enzyme binding. We chose
chemically modified bovine serum albumin (cBSA) as an inexpensive, versatile protein-glue for
these studies.
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3.1. Cationization of BSA by reacting its side chain COOH groups with

tetraethylenepentamine (TEPA) via carbodiimide coupling. The resulting chemically modified
BSA (cBSA) indicated 78-fold higher affinity for GO than BSA, and cBSA loaded GO (bGO)
served as a benign host for enzyme binding.
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Bovine serum albumin (BSA, M.wt. 64,000 Da) is an abundant, water-soluble, globular serum
protein, often used to control protein adhesion to a variety of solid surfaces like glass, 24
stainless steel,25 titanium25 and graphene oxide.26 We took advantage of this property of BSA to
bind to variety of inorganic solids, but chemically modified its residues to control interactions
with other molecules in a predictable manner. The chemistry was selected to highly cationized
BSA (cBSA) such that it would bind with high affinity to negatively charged GO, on one hand,
and also to enzymes and proteins, on the other hand. The high affinity binding of cBSA to
negatively charged DNA (binding constant of 4.6 x 107 M-1), for example, was previously
demonstrated in our laboratories. 27 This combination of high affinity binding of cBSA to
biomolecules and the intrinsic affinity of BSA for GO17,26,28 suggest that cBSA might serve as an
excellent protein-glue. One potential advantage with our approach is that the functionalities and
charge on BSA can be tuned systematically by the modification of its side chains. For example,
the COOH groups of the aspartate and glutamate side chains of BSA can be modified to the
corresponding amides by carbodiimide chemistry (Scheme 3.1) and the net charge on the
modified BSA controlled by the extent of modification. Chemical modification can potentially
provide a versatile approach for the generation of protein-glues for the benign binding of a wide
variety of enzymes and proteins, and it provides opportunities to fine-tune enzyme-GO
interactions. Here, we show that cBSA (Scheme 3.1) binds avidly to GO, and the resulting
cBSA-coated GO (bGO) binds met-hemoglobin (Hb), Glucose oxidase (GOx), Horseradish
peroxidase (HRP), BSA, Catalase (Cat), lysozyme (Lyz) and Cytochrome c (Cyt c), which
served as a representative set of proteins and enzymes.

As the loading of cBSA on GO

increased, the extent of bound enzyme structure retention and activities improved continuously,
or exceeded those of the unbound enzymes. These data demonstrate that GO interactions with
enzymes can be controlled systematically at the molecular level, for the first time, and it can be
biophilized for benign adsorption of numerous enzymes and proteins.
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3.3. Materials and Methods

3.3.1. Materials. Graphite flakes, Guaiacol, KMnO4, Glucose oxidase (GOx, Aspergillus niger,
90%) and succinic anhydride were purchased from sigma Aldrich (St. Louis, MO). Peroxidase
type 1 from horseradish (HRP; specific activity of 356 U/mg) and equine heart cytochrome c
was purchased from Calzyme laboratories Inc. (San Luis Obispo, CA). Met-hemoglobin (Bovine)
was obtained from MP biomedicals, LLC (Solon, OH).

3.3.2. Synthesis of Graphene Oxide. Graphene oxide was synthesized by modified Hammers
method29. Graphite (0.5 g) was suspended in 15 mL conc. H2SO4 under an ice bath. 1.5 g of
KMnO4 added to that in portions with constant stirring. The reaction mixture was kept at 50°C
and after 3 h, 35 mL distilled water was added and then stirred for 15 more minutes. Then an
additional 150 mL of water were added, followed by 10 mL 30% H2O2 when the color changed
to bright yellow and has quenched. The mixture is filtered and washed with 200 mL 10% HCl
and then with water until the pH of the solution reaches 7. The oxidized graphite was sonicated
for 1 h to exfoliate and centrifuged at 4000 rpm for 2 hours to remove any unexfoliated graphitic
oxide. The supernatant was collected. The sonication followed by centrifugation repeated 2
more times and the stock graphene oxide solution was collected. Raman Spectroscopy XRD
and AFM characterized GO. GO solution (0.7 mg/mL) in water bought in to 10 mM sodium
phosphate at pH 7.0 by extensive dialysis (3 times; 4 hrs each) in an 8000 kDa semi permeable
membrane. This GO solution in buffer used for 5-7 days.

3.3.3. Chemical Modification of Bovine Serum Albumin (BSA). Tetraethelenepentamine
(TEPA) was dissolved in 30 mL deionized water (75 mM) and pH was adjusted to 5.0 using dil.
HCl. BSA solution (0.376 mM, 10 mL) was added to the stirring TEPA solution and allowed to
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equilibrate for 20 minutes. 150 mM 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) was
added to the mixture in small portions and stirred for additional 40-50 minutes. 10 mL water was
added to the reaction mixture to quench the reaction. This solution was dialyzed against 10 mM
Sodium Phosphate buffer at pH 7.0 to remove byproducts and excess reactants. Dialysis was
done using an 8000 Da semipermeable membrane for 3 times (3 hours each). Chemical
modification was confirmed by agarose gel electrophoresis and zeta potential measurement
(~+4 mV; data not shown) of the modified protein. Proteins were labeled with the flurophore by
mixing BSA or cBSA (40 µM; 40 mL) with 100 µL fluorescence isothocyanate (6mg/mL in DMF)
for 1 hour. Unreactive FITC was removed by dialyzing (8000 Da membrane) the protein
samples with 10 mM phosphate buffer at pH 7 for 3 hours.
3.3.4. cBSA binding to GO. GO and chemically modified BSA were prepared by following
reported procedures27,30 and the methods are briefly described in the supporting information
(see Supporting info, methods section). Biophilic graphene oxide was prepared by controlled
addition of cBSA (100 µM; 1 mL- 12 mL) to GO suspension (1 mg/mL; 25 mL) and stirred for 20
hours at room temperature in 10 mM sodium phosphate buffer at pH 7.0. The binding was
monitored by zeta potential measurements and the extent of cBSA binding was tailored as
needed to produce bGO samples with increasing loadings of cBSA. This protocol was followed
for the preparation of bGO(-35), bGO(-22), bGO(-11) and bGO(+5) with particular
concentrations of cBSA (5-65 µM).

3.3.5. Fluorescence quenching experiments. Fluorescence studies were done in a plate
reader (FlexStation® 3, Molecular Devices, Sunnyvale, CA) in a standard opaque 96 well plate
of 0.250 mL in volume. Fluorescence quenching of GO with FITC labeled BSA and cBSA was
done. Protein samples (1 µM, 250 µL) were taken and aliquots (5-70 µL) of GO (0.7 mg/mL)
were added to it and monitored FITC emission at 525 nm on excitation wavelength at 485 nm.
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Inner filter effect from GO was found to be negligible throughout the measurements. The data fit
into Stern-Volmer equation and plotted here. But best fit observed for modified Stern-Volmer
equation,31
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where [Q] = concentration of the quencher; F0 = Fluorescence intensity when [Q] = 0; F =
Fluorescence intensity at given [Q]; Ka = Bimolecular quenching constant, and fa = fraction of the
initial fluorescence accessible to the quencher.

3.3.6. Binding Experiments. Solutions of protein and graphene oxide (0.6 mg/mL) samples
were equilibrated for around 1 hour, mixed well and centrifuged at 12,000 rpm for 10 minutes to
separate the free protein from the bound. In Hb binding experiment, for example, 333 µL GO
(0.6 mg/mL) and 500 µL Hb (120 µM) mixed and made up to 1 mL using 10 mM phosphate
buffer at pH 7.0. Final concentration of Hb, Cyt c nad GOx used in each samples was 60, 60
and 5 µM respectively. The free protein concentration was calculated spectrophotometrically.
The concentration of bound protein calculated from the data and plotted. A detailed binding
isotherm for Cyt c binding to GO, bGO(-35), and bGO(+5) were carried out in 10 mM sodium
phosphate buffer at pH 7.0 and compared the results. Cyt c was varied (0-70 µM) and same
concentrations of bGOs (0.2 mg/mL) were used. The concentration of the bound protein was
calculated as mentioned above. Binding constant of cBSA modification to GO was calculated
using Langmuir-Freundlich (LF) equation .
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----(equation 3.2)32
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where Q is the amount of protein adsorbed per gram of GO, Qm is the saturated adsorption, K is
the LF binding constant, C is the equilibrium concentration of cBSA

(µM) and c is the

heterogeneity index.

3.3.7. Zeta Potential measurements. Zeta potential measurements were performed using
laser Doppler velocimetry method in a Zeta Potential Analyzer (ZetaPLus, SR-516 type
electrode, Brookhaven, Holtsville, NY). Sample suspensions were prepared in 10 mM sodium
phosphate buffer at pH 7.0. GO or bGO suspensions (0.65 mg/mL) were equilibrated with
protein solutions for 1 hour at room temperature prior to the measurements. Zeta potentials
were measured in a 4 mL polystyrene cuvette and 3 runs were performed for each sample.
Smoluchowski fit (provided by the manufacturer) for corresponding electrophoretic motilities of
the samples were used to calculate zeta potential responses.

3.3.8. AFM Studies. Atomic Force Microscopy (AFM) of the samples was performed using a
Bruker Dimension Icon (Santa Barbara, CA).

Sample suspensions were sonicated for 20

minutes before AFM studies. The samples for AFM were prepared by the following method.
First a small droplet (25 µL) of the sample suspension was put on a freshly cleaved mica sheet
attached to a brass stub, left for 2h in a desiccator to remove the solvent slowly.

3.3.9. Powder X-Ray Diffraction Studies. Protein/GO suspensions with maximum loading of
the protein in 0.6 mg/mL GO in 10 mM phosphate buffer at pH 7.0 were drop-casted on glass
slides and air dried (3-4 days). The powder X-ray diffraction studies were performed using
Rigaku Ultima IV diffractometer (Woodlands, TX) with CuKa (λ = 0.15406 nm) radiation. Beam
voltage and beam current of 40 kV and 44 mA were used, respectively. A two-theta range of 0.5
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– 35 º was used with a continuous scan rate of 2.0 º/min. The interlayer spacing of graphite
powder, GO and GO/protein complexes were measured from the 00l reflections (l= 1, 2, 3 etc.,).

3.3.10. Circular Dichroism. The CD spectra was recorded on a Jasco J-710 CD spectrometer
(Easton, MD) for proteins before and after binding with GO or bGO (0.04 mg/mL) using 0.05 cm
path length quartz cuvette from 260 – 190 nm. Sensitivity of 20 mdeg, bandwidth 1.0 nm,
response time 4 s, resolution 0.5 nm, speed 50 nm/min and average of 3 scans were recorded.
The CD spectra was corrected by subtracting the buffer signal, and the data has been
normalized as ellipticity per micro molar enzyme per unit path length. Structure retention of the
conjugates was compared with that of free enzymes taking intensity at 222 nm as a standard.
Signal intensity at 222 nm from cBSA was subtracted from the samples containing that in
excess. The α -helicity of the proteins was using the following relationship

α − helicity =

< = >???
@=A

--- (equation 3.3),

where M is the molecular weight of the protein, θ222 is the ellipticity of the protein
concentration C and N is the number of amino acids in the protein. Percentage α -helicity was
calculated by comparing it with that of free proteins.
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3.3.11. Enzyme Activity Studies. Molecular Devices flex station plate reader was used for
kinetic studies. Activities were measured by suitable modification of published protocols33, 34 and
activities of the bound proteins have been compared with untreated enzymes, under similar
conditions of buffer, temperature, pH and ionic strength. The GO/Enzyme and bGO/Enzyme
complexes were suspended in 10 mM phosphate buffer pH 7.0. Enzyme assay vary with
proteins, for example peroxidase activity of heme containing enzymes and oxidase activity of
GOx were used. Kinetic data were plotted using Kaleida Graph (version 4.1.3), and the initial
data points were used to calculate the initial velocities and specific activities.

3.3.12.

Raman

Spectroscopy.

A

Renishaw

Smith

inVia

Raman/IR

microprobe

(Gloucestershire, UK) was used with a 633 nm wavelength for the Raman spectroscopy of GO
(0.65 mg/mL), bGO(-35) and GOx/bGO(-35) suspensions, and ten scan were averaged for
better signal to noise ratio.
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3.4. Results

A novel biophilization approach for the high affinity, favorable, benign binding of enzymes and
proteins to GO is reported here. These investigations are described below.

3.4.1. Chemical modification of BSA and its interaction with GO. Our strategy has been to
find a protein ‘glue’ such that it binds to GO on one hand, and also binds to the enzymes of
interest, on the other hand. We chose to chemically modify BSA (cBSA) to produce a number of
different derivatives, and cBSA was produced by coupling the carboxylic acid groups on the
glutamic and aspartic acid side chains of BSA with tetraethylenepentamine (TEPA), via the
standard carbodiimide coupling chemistry (Scheme 3.1, top).
Production of BSA-TEPA was monitored by agarose gel electrophoresis and the charge on
cBSA was determined to be +24, as estimated from the migration in the agarose gel (Figure
3.1.A) by comparing the migration distances of BSA and cBSA. Considering the charge on BSA
to be -1835 we estimate the charge on the cBSA to be +24. The circular dichroism (CD) spectra
of cBSA indicated significant (~75%) retention of its native-like structure (Figure 3.1.B).
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A

B

Figure 3.1. A. Agarose gel electrophoresis of BSA-TEPA (cBSA) (top lane), compared with
native BSA (bottom) at pH 7.0. Modification of carboxylic acid side chains with TEPA flipped the
charge of BSA and cBSA moved to the negative electrode, when an electric field was applied.
Based on the migration distance in the electric field the average charge of cBSA found to be
+24 at pH 7.0. B) CD spectra of cBSA (green) in comparison with BSA shows that the chemical
modification has not substantially affected the secondary structure of the protein.
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3.4.2. cBSA Binding studies with GO. Binding was quantified by fluorescence quenching
experiments, where we exploited the fact that GO quenches the fluorescence of a number of
dyes.10, 36 For example, we labeled cBSA with fluorescein isothiocyanate (FITC), purified the
cBSA-FITC conjugate by dialysis, and tested binding to GO by fluorescence spectroscopy.

The gradual addition of GO suspensions to cBSA-FITC quenched fluorescence rapidly (1
µM protein, Figure 3.2.A and B), and in control experiments, where BSA-FITC was used
instead of cBSA-FITC under otherwise identical conditions, fluorescence was quenched very
poorly (Figure 3.2.C and D). Thus, cBSA-FITC binds to GO with greater affinity than BSAFITC. The quenching data were fitted to equation 3.1, and the corresponding Stern Volmer
constant for association (Ka) has been found to be 228 mL/mg of GO or 1.64 x 104 M-1 where
the molar mass of a C6 unit was used for GO concentration estimates. Similar analysis of the
quenching of BSA-FITC fluorescence by GO (Figure 3.2.D) indicated Ka value of 2.1±0.4 x 102
M-1, and by comparing the two quenching constants, cBSA-FITC appears to bind nearly 78-fold
stronger than BSA-FITC.
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A

C

B

D

Figure 3.2. A. Quenching of cBSA-FITC fluorescence by GO. Fluorescence Spectra show the
quenching of fluorescence of cBSA-FITC (B) and BSA-FITC (C) by GO. Clearly, quenching is
very prominent in case of chemically modified BSA. D. Modified Stern-Volmer plots (equation
3.1) for the quenching of cBSA-FITC (blue lines) and BSA-FITC (red lines) by GO. The inset
shows the corresponding Stern-Volmer plots.
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Figure 3.3. A. Zeta potential titrations of GO (1 mg/ml) with increasing concentrations of cBSA.
The data points are averages of three measurements, and in some cases, the error bars are too
small to be visible. B. Langmuir–Freundlich Isotherm of cBSA binding to GO. Binding
parameters were calculated by non-linear fit (R2=0.997) of the isotherms following equation 3.2.
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The binding of cBSA (+24) to GO was also confirmed by zeta potential titrations (Figure
3.3.A), where aliquots of cBSA (0-65 µM) were added to GO suspensions (1 mg/ml, phosphate
buffer at pH 7.0). GO charge increased progressively from -61 to +5 mV as a function of
increasing concentrations of cBSA. Corresponding control experiments by replacing cBSA with
BSA show only minor changes in GO charge (Figure 3.4).
In another set of experiments, we examined the binding directly by centrifugation studies,
where mixtures of cBSA and GO were equilibrated for 30 minutes and centrifuged to separate
the bound protein from the unbound. This data was then plotted to construct the corresponding
binding isotherms (Figure 3.3.B) and analyzed using Langmuir-Freundlich (LF) isotherm
(equation 3.2).31 The analysis indicated a binding constant (Kb) of 2.73 x 105 M-1 and
heterogeneity index (n) of 0.67 for cBSA, from the non-linear regression analysis of the binding
isotherm (Figure 3.3.B). Thus, three different approaches were used to examine the binding of
cBSA to GO. Encouraged by these results, we examined the binding of a small set of proteins
and enzymes to cBSA/GO as a function of cBSA loading.
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Figure 3.4. Comparison of change in zeta potential on binding BSA and cBSA to GO. Zeta
potential of the system gradually changes from -60 mV to +5 mV upon addition of cBSA (red).
Addition of BSA caused change in zeta potential to – 30 mV but large error in the measurement
was noted that might be due to the heterogeneity of the system.
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3.4.3. Biophilization of GO: We prepared GO (1 mg/mL) with increasing loadings of cBSA (0,
4, 35, 45 and 65 µM, bound per mg of GO) which resulted in discrete bGO samples, and the
zeta potentials of these samples were -60, -35, -22, -11 and +5 mV, respectively. These are
labeled as GO, bGO(-35), bGO(-22), bGO(-11) and bGO(+5) for future reference.

Initially, the

binding of Cyt c these bGO samples was examined systematically and then the binding of a
small set of proteins and enzymes has been evaluated.

A

B

Scheme 3.2.A. Biophilization of GO with increasing loadings of cBSA (A through D, 0, 4, 35, 45
and 65 µM, bound per mg of GO) gave rise to four different bGO samples with decreasing
negative charge or increasing positive charge (given in parenthesis). B. Binding of Cyt c to GO(60) (red line), bGO-35(blue) and bGO(+5) (green) as a function of increasing concentrations of
Cyt c.

3.4.4. Cyt c binding to bGO. Cyt c was chosen as a good model system to control its binding
behavior with GO, as this protein was known to show higher electrochemical redox activity on
GO. 37

The binding affinities of Cyt c with GO and bGO samples were determined by

centrifugation studies. Mixtures of GO or bGO (0.15 mg/ml) and increasing concentrations of
Cyt c (0-80 µM) were equilibrated for 30 minutes, followed by centrifugation to separate the
bound Cyt c from the unbound protein. Binding isotherms were constructed from these data
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(Scheme 3.2.B) and analyzed by the LF model (R2 > 0.98) Cyt c had high affinity towards the
negatively charged GO (Kb = 7.0 x 104 M-1) and bGO(-35) and binding saturated at 45-50 µM
Cyt c while its binding to bGO(+5) has been considerably poor(Kb = 3.5 x 103 M-1). Clearly,
protein binding was influenced by the net charge on bGO or GO, and hence, we tested binding
as a function of the isoelectric point of the protein.

3.4.5. Binding as a function of protein isoelectric point: Often it is presumed that protein
binding is dominated by electrostatic interactions, and we tested this premise by examining the
binding of a few proteins with GO and its derivatives. The binding of GOx, Hb and Cyt c (pI; 4.5,
6.8 and 10 with net charge at pH 7.0 as -65, -1, +7, respectively)38,39,40 was examined by using
GO, bGO(-35) and bGO(+5), and evaluated how the charge on the adsorbent influences protein
binding (Figure 3.5.A). The maximal loadings of the three proteins (% w/w) were obtained by
equilibration of the adsorbent with excess protein, separation of the unbound protein and
quantifying the amount of protein bound to the adsorbent. The % maximal loadings were plotted
(Y-axis) as a function of adsorbent charge (X-axis) as well as the pI values of the protein (Zaxis). At first glance, binding seemed to correlate with favorable electrostatic interactions but
there are some interesting trends that did not obey this expectation. That is, proteins with a net
positive charge should consistently show higher affinities with strongly negatively charged GO,
while proteins with net negative charge are expected to show poor binding. The loadings varied
from 88% to a high value of 453% (w/w). The data clearly showed that protein binding is not
entirely driven by electrostatic interactions, as discussed later.

3.4.6. Zeta Potential Titrations: To gain insight into the binding mechanism, we examined the
net charge on the nanosheets as the protein binding progressed by zeta potential titrations
(Figure 3.5.B). The zeta potential of GO(-60), for example, decreased steadily as a function of
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increasing concentrations of Cyt c (0-115 µM, red curve) and reached a plateau at -6 mV, but
the binding did not reverse the net charge on the nanosheets or even completely neutralize it,
despite the net positive charge on Cyt c. Binding of Cyt c to bGO(-35) followed similar trend
(blue line) but binding saturated at around the same Cyt c concentration as with GO, and zeta
potential also reached a plateau at -6 mV, the same as in the case of GO/Cyt c. This is
surprising. On the other hand, Cyt c binding to bGO(+5) (green line) indicated essentially minor
changes in the zeta potential, even though there has been considerable loading of Cyt c to
these nanosheets (Figure 3.5.A).

Binding of GOx and Hb also affected the surface potential of GO or bGO surfaces (Figure
3.6) and in general, when the loading of the protein was higher, modulation of zeta potential has
been higher. The binding of the proteins to these nanosheets could occur at the edges or on
their surfaces, and these two binding modes can be distinguished by powder XRD and AFM
studies, as described below.
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Figure 3.5. A. Maximal loadings (% w/w) of GOx, Hb and Cyt c to GO(-60), bGO(-35), bGO(+5),
at pH 7, are shown. The data is arranged with increasing pI of the protein on X-axis and
increasing charge of the adsorbent on the Z-axis. All measurements were averages of three
trials and in some cases, the error bars are too small to be visible. B. Zeta potential as a
function of Cyt c loading on bGO. Protein binding increased the zeta potential in all cases.
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Figure 3.6. Zeta potential titration data for (A) GOx and (B) Hb, binding with different bGO
samples. Change in zeta potential was proportional to extent of binding in each case. For
example Hb interacts well with GO and GOx is not (red lines), therefore a shift in zeta potential
is prominent in the former case than in later.
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3.4.7. Powder XRD and AFM studies: Powder XRD data was collected after drop-casting a
sample of the protein/bGO suspension on glass cover slips and allowing to air-dry them. Protein
binding on the nanosheets should expand the interlayer distances of GO from 7.4 Å to
appropriate values that correspond to the respective diameters of bGO/protein intercalation
products after restacking of the protein embedded GO layers (Figure 3.7.A). The powder XRD
diffractograms of GO and bGO(+5) showed distinct peaks at 7.4 and 51 Å, respectively, while
bGO(-35) did not show any discernable peaks. Binding of GOx, Hb and Cyt c to bGO(-35)
indicated clear peaks with d-spacings of 97, 58, and 37 Å, respectively (Figure 3.7.B and C).

Control experiments with films in the absence of bGO(-35) showed no XRD signals in the
region of interest (Figure 3.7.A). The d-spacings of the protein/bGO(+5) samples clearly show
the binding of the proteins on the basal plane of GO before they restack up on drying, but
binding at the edges could not be ruled out. Therefore, AFM studies were done to examine the
extent of binding on the surface vs edges of the nanosheets.
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C
Figure 3.7. A. Protein bound, exfoliated GO sheets in solution (left), which are reassembled to a
layered structure (right) upon air-drying the suspension on a glass slide. B. Powder XRD data
of protein/bGO(-35) films are shown. C. The d-spacings correlated with known diameters of the
corresponding proteins.
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Figure 3.8. AFM images showing decoration of cBSA on GO surface. Height profile analysis
on bare GO sheets indicates a uniform surface. But bGO(-35) surface showed an uneven
surface with 3-4 nm height, corresponding to the size of cBSA bound to GO. B. Raman spectra
of bare GO (red), cBSA modified GO (green) and GOx bound BGO(-35) (blue). Both D (~1350)
band and G (~1590 cm-1) band for graphene oxide was appeared at expected positions. Peak
positions were remaining unchanged after protein modifications indicate that electronic
environment of GO is preserved.
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The AFM images were collected after mounting the samples on a freshly cleaved mica
substrate and the corresponding images are shown. Surface topography of the bare and
biophillic graphitic oxide (GO and bGO(-35)) samples were shown in Figure 3.8.A. Atomic force
micrography of the bare GO sample which presents a planar lamellar structure with distinct
edges in accordance with the surface topography of the bare GO nanosheets (Figure 3.9.A (i)).
Figure 3.9.A (ii-iv) are the surface topographies of bGO(-35) samples measured by atomic
force microscope at three different magnifications. All of these images suggest the structural
characteristic of a GO surface is maintained after protein loading. Figure 3.9.A (ii-iv) shows the
protein deposition on the surface of GO. Moreover, a close look at Figure 3.9.A (iv) depicts a
uniform deposition of proteins on the nanosheets (Figure 3.8) (i) is the AFM image of a bare
GO sample, GO samples have the planar lamellar surface structure with sharp edges
presenting a polygonal morphology of the nanosheets. Figure 3.9.A (ii-iv) is the AFM image of a
bGO (-35) sample in water where GO sheets are covered with small dot like formations
representing the cBSA adsorption. In Figure 3.9.A (iv), it is clearly visible that planar GO
nanosheets are almost uniformly covered with the protein. The line scans of the micrographs
indicated 3-4 nm height for cBSA bound to GO and bGO(-35) (Figure 3.8), which is comparable
to the XRD data (51 Å).

Likewise, Cyt c, Hb and GOx bound to GO or bGO was characterized by AFM (Figure
3.9.B). Evidently, proteins decorated the sheets and the lamellar nature of the staring bGO has
been preserved. Proteins appeared as small islands on the nanosheets rather than a uniform
deposits. Interestingly, AFM height measurements for GO/GOx showed the peak height
increment of 85 Å over the bGO surfaces which supported the d-spacings estimated by powder
XRD experiments in representative samples. The AFM image clearly shows the proteins are
deposited in form of islands at regions on the surface. The height profile measured by the AFM
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peaks at these precise locations, therefore the peak height in the height profile line scan
acquired from the AFM is the correct parameters to describe the protein deposition on GO
surface. The Raman spectrum shown in Figure 3.8.B indicates a red shift of the D-band by 10
cm-1, and is indicative of interaction of the c-BSA with the edge and steps present on the GO
surface. Covalent modification of the GO surface with BSA has shown red shifts of both the D
and G band by 50 cm-1.41
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Figure 3.9. A. AFM images of GO and bGO(-35) at different magnifications. cBSA decoration
increased the plate thickness. B. Binding of Cyt c and Hb to GO and the binding of GOx to
bGO(-35) is clearly demonstrated in these images.
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3.4.8. Structure and Activity Studies of the Bound Proteins. Thus, far we have shown that
the GO layers can be loaded with cBSA, and the loadings of both GOx and Hb improved with
cBSA, but it is also important to evaluate the extent of native-like structures of the bound
proteins. Circular dichroism (CD) studies were done to examine the secondary structures of the
bound proteins. The CD signal intensity at 222 nm of the bound protein is compared with that of
the corresponding unbound protein (Figure 3.10). Generally as the underlying cBSA
concentration increased, the bound protein structure improved, and resembled that of the
unbound protein.
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Figure 3.10. Comparison of CD spectra of bGO charge ladders/Enzyme assemblies with free
enzyme. Figure A, B and C shows far UV CD spectra for GOx, Hb and Cyt c respectively. D
shows the change in heme environment of Hb/bGO derivatives. Söret band CD of Hb indicates
the disturbance of Heme environment in Hb/GO and Hb/bGO(-35) cases worth noted.
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The extent of retention of the structure of the bound protein (%) was calculated by
comparing the intensity of the CD band of the unbound protein at 222 nm with that of the bound
protein at the same wavelength (Figure 3.11.A). The % structure retention was plotted as a
function of cBSA loading or charge, which are measures of the extent of modification of the GO
surface. When Cyt c and Hb are bound to bare GO, they lost almost 90% of their CD signals
(blue and red lines) but as the cBSA loadings increased, the proteins began to recover their CD
signals. On the other hand, GOx retained most of its structure on bare GO (22% loss) but also
improved with cBSA loading (green line). In general, increased loading of cBSA, improved
bound protein structure.

In another study, we examined activities of bound enzyme, as a function of increasing cBSA
loadings (Figure 3.11.B). The activities of Cyt c, GOx, and Hb bound to GO, bGO(-35) and
bGO(+5) were recorded by recording the initial rates and specific activities have been calculated
from this data (10 mM sodium phosphate buffer at pH 7.0). Interestingly, the peroxidase-like
activity of Cyt c (6.4 x 10-4 M-1s-1) was enhanced ~15-fold (9.19 x 10-3 M-1s-1) on binding to GO
(black bars) and activities reached that of the unbound Cyt c upon binding to bGO(-35) or
bGO(+5). Specific activities of unbound Hb (2.93 x 10-3 M-1s-1) and GOx (5.31 x 10-3 M-1s-1)
decreased on binding to GO to 50 and 80%, respectively (black bars). However, their binding to
bGO(-35) improved the activities (red bars) and on binding to bGO(+5) the activities were nearly
the same as those of the corresponding unbound enzymes (green bars).

In the case of

bGO(+5), the bound enzyme activities were nearly matched to those of the unbound enzymes
and proteins. Therefore, except with Cyt c, both Hb and GOx indicated improved activities with
cBSA loadings.

112

Chapter 3

A

Results

B

Figure 3.11.A. Plot showing protein structure retention (%) as a function of charge/extent of
biophilization (Δζ). Approximate concentration of cBSA used for biophilization of GO (1 mg/mL)
shown on the top X-axis. B. Retention in enzymatic activity with increasing loadings of cBSA.
Cyt c showed exceptionally high activities at GO and bGO(-35).
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Figure 3.12. Enzyme recyclability study of GOx/bGO(+5) activity. The enzyme composite was
recovered after each cycle by centrifugation followed by washing.
calculated by taking specific activity at first cycle (red line) as 100%.
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3.4.9. Extension to binding of other proteins and enzymes. To test if cBSA would passivate
GO for enzyme binding or biophilization of its surface, we examined an additional set of proteins
and enzymes (BSA, catalase (Cat), HRP and lysozyme (Lyz)). Solutions of these proteins were
equilibrated with GO or bGO(+5), bound proteins were separated from the unbound proteins,
and the CD spectra of the bound proteins have been recorded. The extent of structure retention
was estimated as before (Figure 3.13. A-D) and the extent of structure retention of all the 7
proteins is compared (Figure 3.13. E). The blue bars correspond to the % retention of the CD
intensities of proteins bound to GO, and most of these proteins lost a significant portion of their
native-like structures. On the other hand, red bars represent the extent of structure retention for
proteins bound to bGO(+5), and these samples indicated extensive retention of their structures,
close to those of the unbound proteins, 100%.

These data clearly show that the adsorption of most enzymes on GO lose their native like
structures, while they retain most of their native-like structures on adsorption onto bGO(+5).
Thus, GO can be converted into a more biologically compatible material by simple adsorption of
cBSA, and this discovery expands the utility of bGO for a variety of new and exciting biological
applications.
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Figure 3.13 .Far UV CD Spectra of A. BSA B. Catalase C. HRP and D. Lysozyme at free state
(blue), bound to GO (red) and bound to bGO (green). Improved structure retention (E) and
activity retention (F) on bGO(+5) (red bars) in comparison to GO (blue bars) for different
enzymes, which are arranged in the order of increasing pI.
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3.5. Discussion

Protein-GO interactions are driven by several factors which include, but not limited to,
electrostatic, hydrophobic, hydrophilic, and dipolar interactions. Thus, control of this BioNano
interface is challenging because of the complexity of these systems. Graphene oxide is
attractive to biologists as a platform for biomolecular immobilization. Even though a large
number of functional groups and large surface area of GO favors effective binding of proteins,
hydrophobic nature of the surface is not benign to many proteins.17 Therefore, converting GO
into a biocompatible material is both challenging and rewarding. Our attempt in this report was
to control the surface characteristics of GO in systematic manner so that the structure and
function of bound biomolecules can be improved to those of the corresponding unbound
biomolecules.

Our hypothesis is that adsorption of a chemically modified protein would serve as a glue to
bind GO on one hand and also provide favorable interactions for the benign binding of a variety
of biomolecules on its surface. We have chosen BSA for this purpose due to its affinity for a
variety of inorganic surfaces, including GO, and its ability to readily denature and cover
available surface area. BSA also has several acid and amine functions which can be chemically
modified to further control their interactions with both GO as well as the enzymes that are to be
adsorbed on GO. Therefore, chemically modified BSA can serve as an excellent ‘glue’ for
effective, high affinity, benign binding of proteins and enzymes to GO. Previously, unmodified
BSA was used to coat GO for binding of a number of inorganic nanoparticles and limited
applicability for enzyme and protein binding.28 But the utility of the unmodified BSA is severely
limited, it is negatively charged at neutral pH, and it has poor affinity for anionic GO at neutral
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pH. Hence, we chose chemical modification of BSA which provided greater control over its
properties and facilitated the development of a protein-glue for the biophilization of GO.

There are two major parts to this investigation, one the characterization of the adsorption of
the chemically modified BSA to GO, and the other testing the protein and enzyme binding
properties of cBSA/GO as a function of cBSA loading. Since GO is known to quench the
fluorescence of a number of fluorophores,20,35 we labeled cBSA with FITC and measured its
binding to GO in fluorescence studies. The Stern-Volmer plots indicated an upward curvature
due to static quenching resulting from the binding of the cBSA-FITC to GO (Figure 3.2.A inset),
and data analysis using reported methods indicated that cBSA-FITC bind to GO 78-fold greater
than BSA-FITC. In another comparison, the direct binding of green fluorescent protein to GO
indicating a Stern-Volmer constant20 of 13.2 µg-1 (9.5 x 102 M-1) In comparison our affinity
constants of 1.67 x 104 M-1 for cBSA-FITC is much larger. Hence, chemical modification
enhanced the affinity for GO, and cBSA has a high affinity for GO.

cBSA binding to GO is also verified by an independent approach, where the net charge of
GO was monitored in the presence of increasing concentrations of cBSA.
measurements are widely used in graphene and GO research, 42 ,

43 , 44

Zeta potential

to demonstrate pH

dependency of suspensions and to validate surface modifications. 45 Our previous work on
protein binding to α-zirconium phosphate nanolayers demonstrated this utility.46 Since cBSA is
strongly positively charged and GO is strongly negatively charged, their binding should reduce
net charge on GO, and zeta potential provided a simple method to monitor these interactions at
the nano-bio interface. The zeta potential of GO increased from -60 to +5 mV by the addition of
increasing concentrations of cBSA (0-70 µM, Figure 3.4) but addition of BSA to GO, under the
same conditions, the charge did not change significantly.
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Binding constant obtained for cBSA from the LF fit was about 10 times higher than apparent
Stern-Volmer constant (Ka) calculated from fluorescence titrations. This may be due to the nonuniform binding of cBSA to GO such that some regions of GO are distinct from the other
regions. This explanation was supported by the heterogeneity index 0.67 deduced from the LF
fit.

Non-linear fit to the Stern-Volmer curve also indicated such heterogeneity where the

fluorophore is not accessible to quenching by GO, meaning that there are some cBSA binding
events that are not observed in the fluorescence titration.

Protein binding to GO is expected to be controlled by several factors, which include
electrostatic and hydrophobic interactions, as well as specific interactions with carboxyl, and
hydroxyl surface groups of GO.19 But, the adsorption of a near-monolayer of cBSA on GO
(please see below) changes the nature of these interactions. To compare and contrast these
interactions, we examined the binding affinities of three proteins on three different versions,
namely GO, bGO(-35) and bGO(+5). Among all the 9 distinct data points shown in Figure
3.5.A, the highest loading of 450% (w/w) was observed for Hb with bGO(+5), where both
binding partners are only weakly charged. Therefore, we conclude that electrostatic interactions
could be important but not the dominant factors in the interactions with bGO.

The next highest loading of 400% (w/w) was observed with Cyt c and GO, and this is
consistent with a high positive charge on Cyt c (+7)39 and strong negative charge on GO, and
loading dropped to 370% with bGO(-35) and then drastically reduced to 66% with bGO(+5).
This outcome is clearly not due to the simple attenuation of electrostatic interactions but rather
due to weakening of the hydrophobic interactions where the cBSA competed for binding to
hydrophobic sites on GO and converted them into more hydrophilic sites. This argument was
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supported by the fact that the extent of structure retention of bound Cyt c increased from 0% to
100% when GO was biophilized with cBSA.

Another evidence for the weak contributions of electrostatic interactions to protein binding
was noted with GOx. GOx is strongly negatively charged, with a charge of -65 mV at pH 7.0,
and it showed poor loading on GO(-60) and bGO(-35), but it showed only minor improvements
for binding to the most positively charged bGO(+5) (88% to 113%). Taken together, this data
clearly show that binding to GO is not dominated by electrostatic interactions. Since, H-bonding
and salt bridges also play vital role in protein-protein interactions adsorbed proteins might make
more H-bonds and/or salt bridges with bGO. Hydrophobic interactions may play a major role
and they can result in the loss of bound protein structures. However, the adsorption of a
sacrificial protein such as chemically modified BSA can effectively block these sites and provide
favorable interactions for binding a number of different proteins and enzymes to the BSAmodified GO.

The average thickness of the cBSA layer on GO surface of bGO(+5) was calculated from
the maximum loadings of cBSA, the d-spacings noted in the powder XRD data, the average
diameter of BSA, and the known surface area of GO (7.05 x 1022 Å2/g).5 The average area of
cross-section of cBSA was estimated to be 2.23 x 1022 Å2/g (using the measured d-spacing of
55 Å radius from the XRD data, Figure 3.7.B), and the area occupied by a monolayer of cBSA
at the maximal loading of (400%, w/w) turned out to be 8.92. x 1022 Å2/g, slightly larger than the
total available surface area. Thus, a near monolayer of cBSA is formed at this high loading,
which is corroborated by AFM height analysis (Figure 3.8). Similar analysis of other proteins
bound to GO indicated monolayer to double-layer formation. We expect this surface to be more
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compatible with proteins and enzymes due to the variety of amino acid side chains present in
the cBSA layer.

A comparative study of equilibrium binding isotherms and zeta potential titrations in specific
cases gives an insight to the nature of protein-bGO interactions. Comparison of zeta potential
data with binding data showed that system strives to achieve electrostatic neutrality as the
protein binding saturates but electrostatic interactions do not appear to dominate the binding.
Because, the maximal loading of GOx to GO (88%) was improved only marginally with bGO(+5)
(113%) even though GOx is strongly negatively charged (-69). When negatively charged GO
interacts with negatively charge GOx, no change in zeta potential was observed even at 80%
loading (Figure 3.6.A). Hb which is nearly neutral at pH 7, on the other hand, showed a
maximum loading of 300% on GO, but its loading steadily improved to 450% with bGO(+5),
These observations implied that the contributions of non-electrostatic interactions also
contribute to the overall binding phenomena.
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Figure 3.14. Experiment showing the irreversibility of biophilization by ruling out the possibility
of displacement of cBSA from GO surface after protein binding. Florescence spectra of BSATEPA-FITC shown in blue, which is quenched by addition of GO (0.16 mg/mL; black line.).
Absence of increase in fluorescence intensity by the addition of GOx (6 µM), Hb (20 µM) or Cyt
c (25 µM) rules out the possibility of any flurophore displacement mechanism.
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Proteins with higher affinity to an immobilized surface can replace the ones with lower
affinities from a given solid surface, which is known as Vroman effect.47, 48 Thus, in the current
case the underlying cBSA layer may be displaced by the added enzymes, and we tested this
possibility in fluorescence labeling studies. Displacement of fluorescently labeled cBSA (cBSAFITC) from GO surface, if any, was followed (Figure 3.14), and there was no displacement of
the underlying cBSA-FITC by Hb, Cyt c or GOx. Thus, cBSA is not being displaced or released
into the solution by other proteins, but it could be serving as a glue for benign binding to GO.

The above conclusion was supported by the structural studies of the bound proteins and
enzymes bound to GO.

Conservation of protein structure is vital for its specific biological

function(s). Protein conformational changes are often encountered on binding to a solid surface
and they are attributed to the opposing contributions of the surface energy of the sold and the
free energy of denaturation (ΔGD-N) of the protein. Specifically, proteins with low denaturation
free energies (less positive values) unfolded or denatured while consuming surface energy of
the solid surface. The surface free energy of GO was estimated to be around 62.1 mJ/m2.49
Proteins with poor stabilities or those that can interact with the hydrophobic regions of GO tend
to lose their structure more readily,20 as illustrated by HRP/GO.18

In the current studies, the Cyt c bound to bare GO, for example, lost almost all of its CD
signal at 222 nm but gained its CD signal with increased cBSA loading and recovered fully on
bGO(+5). The UV CD data show that all three proteins attained nearly 100% retention of their
native-like structures as the cBSA loading is increased, which is novel and advantageous.
Consistent with these data, the Soret CD of Hb/GO and Hb/bGO (Figure 3.10.D) indicated that
heme environment is disturbed on binding to GO but heme environment relaxed to its native like
structure on binding to bGO(+5).

As the cBSA loading increased, thus, the bound protein
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structures improved across the board. The activities of the bound enzymes depended on the
extents of their structure retention on GO, with one exception. Cyt c/GO showed exceptionally
high activity, 15-fold greater than Cyt c (Figure 3.11.A) despite the fact that it lots most of its
structure. Such denaturation and exposure of the heme from Cyt c on GO was cited to be
responsible for enhanced electrochemical signals of Cyt c. 50 We did not observe similar
enhancements in the activities for Hb or GOx, which also contain hydrophobic prosthetic
groups, and therefore it is not a general phenomenon. As the cBSA loading improved, the
activities of bound Cyt c diminished while those of Hb and GOx improved steadily, and activities
reached nearly 100% of their original values on bGO(+5).

To further test the above hypothesis that increases cBSA loading had a positive influence on
the bound enzyme/protein structure, we plotted percent activities as function of their
corresponding percent helicity, for four proteins bound to GO at increasing loadings of cBSA
(Figure 3.15). The plot implies that enzymes/proteins bound to hydrophobic regions of the GO
sheets tend to deform their secondary structures and lower activities. As these regions are
increasingly covered by cBSA, which functioned as a sacrificial protein layer, the fraction of
active enzyme/protein increases proportionately. Protein molecules bound to more hydrophilic
regions of the modified GO, or bGO, could be responsible for improved activities. Thus, it is
likely that binding to the cBSA layer promotes the native-like structure and activity of the bound
proteins.

The effect of biophilization on loading of these proteins is showed in supporting

information Table S1. Protein loading has been improved after biophilization in most of the
cases. Thus, the reported modification of GO with cBSA is a step forward for the development
of functionally active graphene-biomaterials with superior properties when compared to
untreated GO.
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Figure 3.15. Correlation of activity retention with α-helicity (%) of four distinct proteins bound to
GO loaded with increased concentrations of cBSA. The linear relationship between structure
and activity confirms that improved structure translated to improved activities.
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3.6. Conclusions
Non-covalent modification of GO with a systematic manipulation of the bio-nano interface for the
benign and superior binding of a number of proteins and enzymes is reported here. This
approach should be viable and extendable for the preparation of any protein/GO nanomaterials
or to other solid surfaces. The data suggest that electrostatic interactions are important for the
enzyme binding on GO and bGO but other interactions also play a very significant role, perhaps
a stronger role. The sacrificial cBSA on GO provides a protein-compatible surface for improved
activity and structure retention.

These insights are important for further manipulation and

control of the nano-bio Interface for a variety of applications, without compromising the loading
capacity, structure or activities.
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Abstract

Biological Relevance of Oxidative Debris Present in as-prepared
Graphene Oxide

4.1. Abstract
The influence of oxidative debris (OD) present in as-prepared graphene oxide (GO)
suspensions on proteins and its toxicity to human embryonic kidney cells (HEK-293T) are
reported here. The OD was removed by repeated washing with aqueous ammonia to produce
the corresponding base-washed GO (bwGO).

The loading (w/w) of bovine serum albumin

(BSA) was increased by 85% after base wash, whereas the loading of hemoglobin (Hb) and
lysozyme (Lyz), respectively, was decreased by 160% and 100%. The secondary structures of
13 different proteins bound to bwGO were compared with the corresponding proteins bound to
GO using UV circular dichroism spectroscopy. There was a consistent loss of protein secondary
structure with bwGO when compared with proteins bound to GO, but no correlation between
either the isoelectric point or hydrophobicity of the protein. All enzymes bound to bwGO and GO
indicated significant activities, and a strong correlation between the enzymatic activity and the
extent of structure retention was noted, regardless of the presence or absence of OD. At low
loadings (<100 µg/mL) both GO and bwGO showed excellent cell viability but substantial
cytotoxicity (~40% cell death) was observed at high loadings (>100 µg/mL). In control studies,
OD by itself did not alter the growth rate even after a 48-h incubation. Thus, the presence of
OD in GO played a very important role in controlling the chemical and biological nature of the
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protein-GO interface and the presence of OD in GO improved its biological compatibility when
compared to bwGO.
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4.2. Introduction

The role of oxidative debris (OD) present in graphene oxide (GO) in influencing its
interactions with a small set of biological samples such as proteins and cells are examined here.
Interactions of proteins with graphene oxide (GO) are a subject of great interest for their
potential applications in biology.1 A clear understanding of the behavior and the effect of GO on
biomolecules is essential for building functional, catalytic, sensing, medical, and artificial biosystems using GO. Interactions of proteins with certain (nano)materials are well-studied, which
allows one to predict their affinity, structure, and stability.

2

However, GO is a highly

heterogeneous surface with oxygenated functional groups such as hydroxyls, carboxyls and
epoxides that are randomly distributed in a hydrophobic 2D carbon basal plane, along with
peripheral carboxylate functions at the edges of the sheets (Scheme 4.1). The heterogeneity of
GO surface makes it more challenging to predict the behavior of biomolecules at its interface.3

Structural denaturation of proteins at GO, because of unfavorable interactions with
hydrophobic protein interior, adversely affects the protein function. 4 Thus, several surface
passivation approaches were established to mask unfavorable hydrophobic interactions

5

to

prevent protein denaturation. Modulation in enzyme properties such as, decrease or increase in
enzymatic activity,

4,5,6

and complete inhibition 7 on binding of enzymes to GO was illustarted

before. The conformation and orientation of protein surface around the active site play a major
role in determining the modulation of enzymatic activities.

7

Chemical functionalization, 8

reduction, and passivation with proteins9, 10 or polymers,11 can successfully passify GO surface
and stabilize certain proteins and enzymes. Reports suggest that the extent of hydrophobicity
plays a major role in retaining protein structure and thereby their function.
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Recent advances in structural studies of GO have identified the presence of small, highly
oxidized polycyclic aromatic moieties called oxidative debris (OD) in GO suspensions. 12 In
addition, decrease in conductivity,13 increase in fluorescence,

16

increase in electrochemistry14

and decrease in interactions of GO with small molecules 15 are due to the presence of OD.
Treating GO with aqueous base solutions separates this debris (Scheme 4.1), and resulting
debris-free GO (bwGO) has several desirable properties.16 Thus, an interesting question arises
as to how and to what extent OD disturbs biological properties of GO? To date, no such
investigation has been carried out to investigate the role of OD in controlling the interactions of
GO with biological molecules. Biological applications of GO are currently actively pursued.

1, 17

Therefore, it is critical to analyze the nature of bio-GO interface in the absence of OD.
Moreover, the structure of bwGO is closer to graphene than to GO and, therefore, it is important
to examine the influence OD present in GO on its interactions with proteins, enzymes and other
biomolecules.

Here, we report the role of OD at GO interface in controlling the properties of a set of 13
different proteins with increasing isoelectric points (pH where the net charge on the protein is
zero, pI), molecular weight, and the number of surface arginines (SI, Table S1). Our results
suggest that OD plays a major role in controlling the protein binding affinities, as well as the
retention of structure/enzymatic activities. Binding interactions of proteins with GO and bwGO,
structure retention and enzymatic activities were analyzed using multiple spectroscopic methods
(Scheme 4.1). Furthermore, cytotoxicity of GO, bwGO as well as OD and differences in their
toxicities are examined here.

Our current study gives an insight into the fundamental

understanding of bio-GO interactions at molecular level such as the role of surface
functionalities and their nature in determining the affinity, protein secondary structure, and
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enzymatic activities. This information would be valuable for the rational control of protein
behavior at different surfaces using molecular level information of the interface.

Scheme 4.1. Oxidative debris (OD) was removed from graphene oxide (GO), by washing with
aqueous ammonia, and the influence of OD on enzyme-GO interface has been examined. OD
protects the bound enzymes from structure/activity loss and decreases cytotoxicity.
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4.3. Materials and Methods

4.3.1. Materials. Graphite flakes, guaiacol, KMnO4, Glucose oxidase (GOx, Aspergillus niger),
lysozyme (egg white), human serum albumin (HSA), RNase A, betalactoglobulin (BLG),
Ovalbumin (egg white) and myoglobin (bovine) were purchased from Sigma Aldrich (St. Louis,
MO). Horseradish Peroxidase (HRP) and cytochrome c (equine heart) were obtained from
Calzyme laboratories Inc. (San Luis Obispo, CA). Pepsin A, Catalase and Trypsin (Bovine) were
bought from Worthington Biomedical Corporation (Lakewood, NJ). (Met-hemoglobin (Bovine)
was purchased from MP biomedicals, LLC (Solon, OH). The human embryonic kidney (HEK
293T) cells were purchased from American Type Culture Collection (ATCC, Manassas, VA) and
the growth media components viz. Dulbecco’s Modified Eagle Media (DMEM) and Fetal Bovine
Serum (FBS) were purchased from Gibco ® respectively. The metabolic activity of HEK 293T
cells was analyzed with the Cell Counting Kit (CCK-8TM) purchased from Dojindo Molecular
Technologies Inc.

4.3.2. Preparation of GO and bwGO. GO was prepared by modified Hummers method as
reported elsewhere.
ammonia.

16

18

bwGO was prepared by washing GO suspension with aqueous

The base wash procedure with ammonia compared to conc. NaOH has practical

advantage in obtaining pure OD without any solid NaCl (product of neutralization of NaOH with
HCl). Briefly, GO solution (2 mg/mL, 100 mL) was stirred with 40 mL aq. NH3 at 100oC until the
solution was separated in to two different phases (~3 h). bwGO was separated from OD by
repeated centrifugation and was neutralized by repeated washing with water (3-5 times) and resuspended in 10 mM sodium phosphate buffer (pH 7.0). OD was obtained from the aqueous
ammina layer after evaporating the base at 100 °C.
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4.3.3. Fluorescence quenching experiments. FlexStation® (Molecular Devices, Sunnyvale,
CA) was used for this experiment in a standard opaque 96 well plate with 0.250 mL volume in
each well. BSA was labeled with fluorescein isothiocyanate (FITC) for this experiment, with the
assumption that the quenching efficiency of bwGO and GO is near identical. BSA-FITC (1 µM)
was titrated against different concentrations of GO (0.8 mg/mL) or bwGO (0.8 mg/mL). FITC
emission at 525 nm upon excitation at 485 nm was used to tabulate the quenching data. The
data fit into modified Stern-Volmer equation, as reported before (equation 1),
_0/(𝐹
𝐹
_0−𝐹
)=1/(𝑓 𝑎 𝐾
𝑎 [𝑄 ] )+1/𝑓 𝑎

10

----- (equation 1),

where [Q] = quencher concentration; F0 = Fluorescence intensity when [Q] = 0; F =
Fluorescence intensity at given [Q]; Ka = Bimolecular quenching constant, and fa = fraction of the
initial fluorescence accessible to the quencher.

4.3.4. Protein binding studies. Stock solutions of proteins (hemoglobin or lysozyme) were
prepared in 10 mM phosphate buffer pH 7.0. To determine the concentration, absorbance was
measured at 406 nm for hemoglobin and 280 nm for lysozyme. For hemoglobin, a set of
solutions with a concentration range of 5, 10, 15, 20, 25, and 30 μM were prepared in
phosphate buffer pH 7.0 with 0.2 mg/mL GO and 0.2 mg/mL bwGO. For lysozyme, six solutions
of concentrations 10, 20, 30, 40, 50, and 60 μM were prepared, equilibrated with same GO and
bwGO concentrations (0.2 mg/mL). All solutions were allowed to sit for 1 h for complete
equilibration. The solutions were centrifuged for 20 min at 12,000 rpm to aspirate free proteins.
Absorbance measurements were taken for the supernatant liquid at the same wavelengths
previously used to determine the concentration of free protein in the solutions. The adsorption
isotherms were analyzed using Langmuir adsorption model, using the following equation2,19 to
obtain the binding affinity and theoretical adsorption maxima,
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𝑄 = (𝐾
𝑒 𝑄 (𝑠 𝑎 𝑡 )) ⁄ ([1+𝐾
𝐶
𝑒 ]) ------ (Equation 2)
𝐶
where K = dissociation constant (in µM), Q = binding density at equilibrium (in µmol/mg), Ce
= protein concentration (in µM) and Qsat = saturation binding point.

4.3.5. Circular Dichroism Studies. Far UV CD spectra (260 – 190 nm) of protein solutions
were recorded on a Jasco J-710 CD spectrometer (Easton, MD) before and after binding to GO
or bwGO (0.20 mg/mL) using a 0.05 cm path length quartz cuvette. Protein to GO or bwGO ratio
was kept same in all the samples as 50% (w/w) for fair comparison between proteins. All the
spectra presented here were corrected for background signal from the buffer and normalized to
1 µM concentration of the protein. Relative structure retention of the conjugates was compared
using ellipticity at 222 nm of the unbound protein as standard.

4.3.6. Activity Studies. Solutions of hemoglobin (Hb, 8 μM), myoglobin, (Mb, 12 μM), catalase
( Cat, 0.8 µM) and glucose oxidase (GOx, 4 µM ) was equilibrated with GO or bwGO (0.2
mg/mL) in pH 7.0 phosphate buffer at 25 oC, prior to activity assays. Peroxidase-like activity20 of
Hb and Mb was performed to compare the activity of proteins bound to GO or bwGO. For the
activity assay, 1 μM hemoglobin, 2.5 mM guaiacol, and 4 mM H2O2 were reacted in pH 7.0
phosphate buffer and the activity was monitored by absorbance measurement of guaiacol dimer
formation at 470 nm. Similarly, for myoglobin solutions, 1.5 μM myoglobin, 2.5 mM guaiacol,
and 4 mM H2O2 were reacted in pH 7.0 phosphate buffer and the activity was determined. For
each of catalase solutions, 0.1 μM catalase and 20 mM H2O2 were reacted in pH 7.0 phosphate
buffer and the activity was determined by following decomposition of H2O2 monitored by
absorption measurement at 240 nm.21 GOx was assayed for its oxidase activity to glucose using
a bienzyme assay coupled with horseradish peroxidase using known protocols.22
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4.3.7. Cytotoxicity assay. The cytocompatibility of OD, GO, and bwGO was investigated by coincubating them with human embryonic kidney (HEK 293T) cells, one of the well-characterized
and widely used human cell lines available. The standard growth conditions of 37°C, 5% CO2
and 95% relative humidity (RH) were maintained throughout the experiment and the intracellular
metabolic rate was determined using CCK-8 kit as described elsewhere. 23, 24

Briefly, 0.5 x 105 cells were seeded in each well of a 24 well plate in 500 µl of complete
growth media [Dulbecco’s The suspensions were further diluted with cell culture media and
quickly vortexed before they were introduced to the adherent cells at a concentration range of
10, 25, 50, 75, 100, 250 and 500 µg/mL. During the co-incubation phase, the cell morphology
was constantly monitored using light microscopy. The intracellular metabolic rate was assessed
after 24 h of co-incubation period by using CCK-8 kit that contains a tetrazolium salt, WST-8,
which got reduced by dehydrogenase activity of live cells to generate a yellow-colored formazan
dye. The amount of the formazan dye thus generated, was quantified spectrophotometrically at
450nm and directly proportional to the number of living cells. Appropriate negative controls,
where the CCK-8 kit reagent (50 µl per well) was substituted with equal volume of PBS, were
used for each concentration of GO, bwGO and OD whereas the positive control consisted of 50
µl of WST-8 solution added to the pristine cells grown in 500 µL of growth media.
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4.4. Results

The presence of OD has been shown to have a role in determining the chemical biological
properties of GO. The interactions of OD-free GO, bwGO, are significantly different from that of
GO, which influenced the structural and functional properties of a wide range of proteins bound
to it. The cell toxicity levels of bwGO and OD are compared with that of GO, and an increase in
toxicity after the removal of OD is noted. Detailed descriptions of our results follow.

4.4.1. Preparation and characterization of bwGO. The as-prepared GO

18

was subjected to

repeated washing with aqueous ammonia, washed with deionized water to remove the base,
and characterized the resulting bwGO as well as the oxidative debris by fluorescence
spectroscopy (Figure 4.1.A and B), and Raman spectroscopy (Figure 4.1.C). The quantity of
OD accounted for ~30% (w/w) in a 100 mL, 1 mg/mL GO suspension. While the bwGO and GO
showed no fluorescence upon excitation at 350 nm, OD indicated broad emission centered
around 440 nm,

16

which is consistent with the presence of polycyclic aromatic debris in OD.

The Raman spectra of GO and bwGO are essentially the same with D band at 1350 cm-1
and G band centered around 1600 cm-1 (Figure 4.1.C), as reported in the literature.

14

These

identical Raman signals before and after base-wash indicated that there have been no
additional defect sites introduced in bwGO upon the base wash. No significant change in ID/IG
ratio.
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D

Figure 4.1. A. Fluorescence spectra of OD (50 µg/mL), GO (150 µg/mL) and bwGO (150
µg/mL) in 10 mM sodium phosphate buffer at pH 7.0. OD shows a characteristic peak at
450 nm (excitation at 350 nm) whereas GO and bwGO showed no noticeable peaks at
the same region, proves the separation step. B. Excitation spectra of OD (200 µg/mL)
show emission maxima around 350 nm, with emission monitored at 500 nm. C. Raman
spectra of GO and bwGO show no significant change in position or intensity of D and G bands.
This proves that no additional defects were introduced to the graphitic plane by base wash. D.
TEM images of GO and bwGO show similar morphology.
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4.4.2. Protein binding studies. We examined the interactions of a few proteins such as bovine
serum albumin (BSA, pI 4.2), met-hemoglobin (Hb, 7.0), lysozyme (Lyz, pI=12) and ten other
proteins in binding studies with GO and bwGO.

We labeled BSA with fluorescein-isothiocyanate (FITC) and examined its binding to GO in
quenching studies. GO quenches BSA-FITC fluorescence and binding has been monitored as
a function of increasing concentrations of GO, at fixed BSA-FITC concentration.

10

The

quenching data have been analyzed by reported methods (Figure 4.2) to estimate the binding
affinities (Ka).
Equation 1 was used to fit the quenching data where [Q] = quencher concentration
(GO/bwGO); F0 = Fluorescence intensity in the absence of quencher; F = Fluorescence intensity
at given [Q]; Ka = Bimolecular affinity constant, and fa = fraction of the initial fluorescence. Thus,
from the slope (1/Kafa) and y-intercept (1/fa) of the fitted line, Ka was calculated. The quenching
constants were compared with the assumption that both bwGO and GO quench the
fluorescence to the same extent, and Ka for GO 5.7 (±0.8) x 103 mL/mg and 6.8 (±1.2) x 103
mL/mg. Clearly, the affinity of BSA increased when OD has been removed.
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Figure 4.2. Quenching of fluorescence of FITC labeled BSA (BSA-FITC) by the addition of GO
or bwGO due to binding to the nanosheets A. Fluorescence spectra of BSA-FITC in the
presence of increasing concentrations of bwGO upon excitation at 485 nm. B. Stern-Volmer fit
for the quenching of BSA-FITC emission by GO (red line) or bwGO (green line).

The

corresponding affinity constants are 5.7 (±0.8) x 103 mL/mg and 6.8 (±1.2) x 103 mL/mg for GO
and bwGO, respectively.
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C
Figure 4.3. Binding isotherms of (A) BSA, (B) Hb and (C) Lyz with GO (0.20 mg/ml) and bwGO
(0.20 mg/ml) in phosphate buffer, pH 7.0. Affinities increased from BSA to Hb to Lyz, which
corresponded to increase in net charge on the protein.
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Binding of proteins to GO and bwGO was also investigated in equilibrium binding studies,
where the samples were equilibrated with protein solutions, and unbound protein has been
separated by centrifugation. Unbound protein concentration was determined by its absorbance
at 280 nm for BSA and Lysozyme, while absorbance at 406 nm has been monitored for
hemoglobin samples. These adsorption isotherms are shown in Figure 4.3.

The affinity of BSA increased after the base wash (Figure 4.3.A, green line), which is in
good agreement with the above fluorescence studies. In the cases of both Hb and Lyz, the
binding to bwGO was similar to that of GO (Figure 4.3.B and C, red lines for GO and blue lines
for bwGO) at low protein concentrations of 5-10 µM for Hb and 10-20 µM for Lyz. But at higher
protein concentrations (>10 and >20 for Hb and Lyz, respectively), protein loading on bwGO
was less than that of GO, under the same conditions. Maximum loading (w/w) of BSA was
increased after base-wash by 85%, that of Hb decreased by 160% and that of Lyz decreased by
100%. The binding of GOx to GO was negligible at low protein concentrations, while bwGO
showed a maximal loading of 64% (Figure 4.4), and in case of GO it decreased to 52%.
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Figure 4.4. Loading efficiency (%) of GOx/bwGO (red) and GOx/bwGO (green) shows
increased binding of GOx to bwGO.
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Langmuir model of Hb and Lyz adsorption to the nanosheets showed clear differences in
binding affinities after base wash (Table 1). The Ka for Hb to GO was 1.9 (± 0.6) x 107 M-1,
whereas the affinity decreased substantially for bwGO (3.6 (± 2.1) x 106 M-1). Lyz showed strong
adsorption to GO with Ka of 8.1 (± 3.5) x 107 M-1, and it decreased to 2.8 (± 0.8) x 107 M-1 for
bwGO. The decrease in affinity is also reflected in the adsorption parameter, Qsat, which
represents the theoretical maximum for monolayer formation of the protein (in µmol) per solid (in
mg). As expected, Hb and Lyz showed significant drop in maximal loadings (2-3 fold), which
suggests weaker adsorption of proteins to bwGO.

Table 4.1. Parameters obtained by the analysis of the binding isotherms using the Langmuir
adsorption isotherm (equation 2)

19

System

Ka (M-1)

Hb /GO

1.9 (± 0.6) x 107

Hb/bwGO

3.6 (± 2.1) x 106

38 (± 8)

0.94

Lyz/GO

8.1 (± 3.5) x 107

530 (± 152)

0.98

Lyz/bwGO

2.8 (± 0.8) x 107

219 (± 26)

0.97

Maximal
Loading, Qsat
(µmol/mg)
124 (± 26)

R2

0.99

4.4.3. Zeta Potential Titrations. To further characterize the changes in bio-nano interactions,
the zeta potential titrations of proteins with GO and bwGO were carried out (Figure 4.5). The
zeta potential of bwGO decreased from -33 mV (no protein added) to -18 mV when Hb
concentration was increased from 0 to 22 µM while that of GO increased from -35 to -12 mV
over the same protein concentration range. This shows the reduced binding affinity of Hb to
bwGO, supporting the adsorption studies. In contrast to Hb, Lyz showed essentially the same
changes with GO and bwGO when its concentration has been increased from 0 to 20 µM.
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Figure 4.5. Zeta potential titrations of Hb (A), and Lyz (B) showed gradual charge neutralization
during protein adsorption to GO and bwGO
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4.4.4. Protein structure retention and circular dichroism studies. Nano-bio interactions
influence bound protein structure, where strong interactions might distort or denature the
protein. The extent of secondary structure retention was analyzed by examining the far–UV
circular dichroism (CD) spectra of the bound protein. The extent of structure retention is
approximated as the ratio of the ellipticity of the bound protein (Ebound) to that of the unbound
protein (Eunbound), both measured at 222 nm, where the 222 nm minimum corresponds to the
alpha helical content of the protein is estimated as RE@222 = (Ebound / Eunbound). The protein
loading was kept at 50% (w/w) where all the proteins showed significant adhesion to the sheets
and spectra have been recorded using very short path length cuvettes (0.05 cm). The spectra
were corrected for scattering, as reported earlier.

10,25
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Figure 4.6. A. Plot of the ratios of ellipticities (RE@222) of bound proteins at 222 nm to that of
the corresponding unbound protein as a function of protein pI values. Red bars correspond to
those bound to GO and green bars correspond to those bound to bwGO. The ratio of 1.0 was
taken for that of the unbound protein. B. Plot of ∆RE@222 as function of pI, where ∆RE@222=
(RE@222 of protein bound to bwGO – RE@222 of the same protein bound to GO).
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The ratio of ellipticities at 222 nm of GO-bound protein to that of the unbound protein
(RE@222) followed the order GOx (4.6) > RNase (9.3) ≥ Trypsin (9.3) ≥ Ovalbumin (4.9) =
Catalase (5.4) > Lyz (11.3) > Pepsin A (1.0) ≥ BSA (5.5) ≥ BLG (5.1) > Cyt c (10) > Hb (6.8) >
HAS (4.7) > Mb (6.8) (Figure 4.6.A). In the case of bwGO, the trend was Trypsin > GOx >
RNase ≥ BLG ≥ Pepsin A > Lyz ≥ Ovalbumin = Catalase > BSA > Hb ≥ Cyt c > HSA > Mb, but
in almost all cases, the extent of structure retention was lower with bwGO than with GO.

A plot of the relative loss of structure when the protein is bound to GO vs bwGO was
generated (Figure 4.6.B) where the relative loss (∆RE@222) is defined as RE@222 of a
protein bound to bwGO minus the RE@222 of the same protein bound to GO. A positive value
of this parameter indicates gain in protein secondary structure while a negative value
corresponds to further loss in structure due to base-wash. The data show that maximal loss in
structure occurred when the pI of the protein is close to neutral value, or when the protein has ~
-15 charge. This consistent loss in secondary structure could result in decreased enzymatic
activities for the bound enzymes, and hence activities of enzymes bound to bwGO were
determined and compared with those bound to GO.

4.4.5. Enzymatic activities. The peroxidase like activity of Hb and Mb, oxidase activity of GOx
and reductase activity of Cat were assayed before and after binding to GO as well as bwGO,
and the data have been compared to deduce the influence of base-wash on the bound enzyme
activities. The percent activities of samples bound to GO or bwGO with respect to those of the
corresponding unbound proteins (100%) are shown in Figure 4.7.A.
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Figure 4.7. A. Relative enzymatic activities of GO/enzyme (red bars), and bwGO/enzyme
(green bars). B. Plot of activity loss enzymes bound to bwGO vs enzyme charge, which shows
lack of correlation between activity loss and enzyme charge.

152

Chapter 4

Results

Oxidase activity of GO/GOx was essentially the same (94%) as that of the pristine GOx, but
significant reduction has been noted (65%) in case of bwGO/GOx. Peroxidase-like activity of
Hb was only 20% upon binding to GO and it reduced further to 5% on binding to bwGO.
Similarly, GO/Mb showed only 14% activity and no measurable activity has been noted for
bwGO/Mb. In case of Cat, the activity was reduced to ~60% on binding to GO while the activity
of bwGO/Cat has been decreased to 45%.

A plot of loss in activity vs enzyme charge (Figure 4.7.B) indicated a poor correlation with
charge, which suggests that electrostatic interactions do not control the enzyme activity at this
interface. To further test these conclusions, we have examined the influence of these materials
on cell growth or cell viability using HEK 293T cells.

4.4.6. Cell toxicity studies. The cytocompatibility of GO, bwGO and OD with HEK 293T cells
up to 24 h of co-incubation was evaluated, the data was obtained by (i) measuring intracellular
metabolism indicated by spectrophotometric measurement of dehydrogenase activity within the
cell and (ii) by observing the extracellular morphology using light microscopy and they showed
no appreciable change in cell metabolism with respect to controls. After co-incubation for 24 h,
the cells revealed a clear dose-dependent decrease in cell metabolism beyond 75 µg/mL
(Figure 4.8). At higher loadings, bwGO was slightly more toxic than GO, within our experimental
errors but both solids were toxic to the cells.

The above intracellular metabolism results were substantiated by light microscopy images
taken at 24 h and 36 h of co-incubation, which revealed significantly stressed cell morphology at
the GO and bwGO concentrations beyond 75 µg/mL. Interestingly, at greater than 75 µg/mL,
bwGO turned out to be slightly more cytotoxic than GO.
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Figure 4.8. Cytotoxicity assays of GO, bwGO and OD when co-incubated with HEK 293T cells
for 24 h. (A) Survival of the cells in comparison to the control shows that the dose-dependent
toxicity of bwGO is higher than that of GO, and OD has no toxic effect. (B) Optical microscopy
images of HEK 293T cells co-incubated with 500 µg/mL of GO (top, left), bwGO top, right), OD
bottom, left) and Control HEK 293 T (bottom, right) for 36 h. Clearly, the cell morphology is
affected by the presence of GO and bwGO (500 µg/mL), whereas OD did not affect cell growth.
The difference in cell toxicity induced by GO and bwGO was calculated using two-tailed
unpaired student’s t test, found to be statistically significant at concentrations above 75 µg/mL
(*ρ < 0.05).
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We also examined the cells exposed to OD isolated from washing GO, but no morphological
or metabolic differences could be observed between cells incubated with OD and control HEK
293T cells. The results obtained from CCK-8 kit, for monitoring intracellular dehydrogenase
activity and light microscopy for assessing the cell morphology correlated consistently
throughout the trials.

To further investigate the influence of OD on these cells, they were detached and
transferred to a six-well plate and monitored for an additional 48 h (this is beyond the first 36 h
of co-incubation). By this time cells exposed to the higher doses of GO and bwGO started to
die, whereas the control cells and cells exposed to OD were still metabolically active. No
appreciable difference in the rate of cell division, morphology or cellular metabolism was
observed between OD co-incubated and control cells.

In summary, the binding affinities of several proteins have decreased, and their structure
retention and enzymatic activities (when relevant) have also been decreased when the OD has
been removed from the GO suspensions.

Thus, OD appears to play an important role in

shielding these bio-macromolecules from any adverse interactions of the underlying graphitic
surface. When the surface is coated with low loadings of BSA (400% (w/w)), the activities of
both Hb and Mb have recovered and even exceeded those adsorbed onto GO. Cytotoxicity
studies show that these materials are toxic to HEK 293T cells at high concentrations (>75
µg/ml) and long exposure times (>24 h).
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4.5. Discussion

Biohybrid materials that are made of biomolecules and carbon based nanomaterials (such
as carbon nanotubes and GO) are thought to offer superior (or improved) biocompatibility,
sustainability and biodegradability over inorganic (nano)materials.

17, 26

GO, a water dispersible

graphene derivative, is one of the promising candidates for rapidly growing biomaterials
1

research. Recently, the presence of oxidative debris within GO suspensions was detected,
which showed significant influence on the material properties of GO.

16, 15, 27, 28

12

However, the

effect of OD on protein-GO interactions has not been evaluated yet. Here, we have studied the
effect of OD in controlling the bound protein characteristics as well as the role of OD in its
cytotoxicity to HEK 293T cell lines.

Adsorption of proteins to both GO and bwGO are marginally different when evaluated
against a small set of 13 proteins whose pI values ranged from 4 to 12. The maximum loading
observed for Hb (pI 6.8) with GO was 320% (w/w), and this translates into an average of ~ 1.3
layers of Hb on the nanosheets, if we assume that the protein occupies the entire surface (7.05
x 10-22 Å2/g) and that the diameter the protein is unchanged upon binding to the nanosheets.
Along these lines, Hb binding to bwGO saturated around an average of 0.7 layers, much less
than that observed with GO. This decrease in the coverage could be due to at least two possible
factors, 1) decrease in intrinsic affinity of Hb to bwGO, or 2) loss in the secondary structure of
bound Hb such that it occupies a larger area on the nanosheets. In support of the former, the
Hb binding affinity of Hb decreased 10-fold, from GO to bwGO. On the other hand, the CD data
analysis indicated only 10% loss in the CD band intensities for Hb bound to bwGO when
compared to that bound to GO. Therefore, the decrease in the maximum loading of Hb is more
likely due to reduced affinity.
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Similar analysis of the CD data of Lyz (ΔRE@222 = -18%), GOx (ΔRE@222 = -14%) and
BSA (ΔRE@222 = -23%) also indicates that protein denaturation is not directly controlling the
loading maxima. Therefore, the changes in interactions at bwGO vs GO could be responsible
for the differences in affinities.

The function of biohybrids can be quite sensitive to the conformation of the bound protein.29,
30

Current studies involving 13 different proteins revealed that there has been a small but

consistent increased loss in protein structure with bwGO when compared to the proteins bound
to GO. To further understand the basis for increased protein structure loss on bwGO, we
examined if there is any correlation between structure loss and protein charge or the hydropathy
index of the protein. The average hydropathy index31 was calculated using Expasy Protparam
tool and it indicated the order Cyt c > RNase A > Catalase > BSA = Lyz > HSA = Mb > GOx >
BLG > Trypsin > Ovalbumin > Hb > Pepsin A, but this trend has no correlation with the
observed trends in RE@222 or ∆RE@222 of these proteins bound to bwGO.
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Figure 4.9. Net charge of the protein at pH 7.0 is not correlated with relative loss of ellipticity at
222 nm (RE@222), after binding to GO (A) and bwGO (B). The differences in ellipticity retention
of bwGO to GO (ΔRE@222) is shown in (C). Lysine content in the protein (%) vs RE@222
observed after binding to GO (D) and bwGO (E). (F) ΔRE@222 as a function of lysines. Sum of
lysines and arginines in the protein as a function of RE@222 after binding to GO (G) and bwGO
(H). (I) ΔRE@222 vs total number of arginines and lysines combined. No noticeable trend is
shown in all cases.
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The relative loss of ellipticity at 222 nm (∆RE@222), which is a measure of the percent
structure retention when compared to that of the unbound protein, did not correlate with net
charge on the protein (Figure 4.9.A-C), or the lysine content of the protein (Figure 4.9.D-F) or
the sum of the number of lysine and arginine residues present in the protein (Figure 4.9.G-I).

On the other hand, the differences in the extents of structure loss when proteins bind to
bwGO vs GO (∆RE@222), however, depended on the percentage arginine content of the
protein as well as the aliphatic index of the protein (Figure 4.10.B). Twelve proteins containing
Arg contents of 0-7% showed strong correlation with the extent of structure loss (Figure
4.10.A), irrespective of their net charge. This strong trend shows the critical role of Arg residues
in the interactions with bwGO. Arg was suggested to interact strongly with GO because of its
ability to form hydrogen bonds as well as its charge and hydration status.32,33,34 Lyz with 8% Arg
content deviated significantly from the plot and could be due to its unusually high
thermodynamic stability.35 In a recent study, strong interaction of lysozyme, an arg rich protein,
with carbon nanotubes (CNT) was demonstrated, 36 and the binding free energy (ΔGbind)
between strongly interacting Args in Lyz with CNT was -5.9 kcal/mol, higher than that of lysine (3.5 kcal/mol).37

159

Chapter 4

A

Discussion

B

Figure 4.10. A. Correlation of the differential loss of ellipticities of GO and bwGO (∆RE@222)
with the protein arginine content. B. Plot of ∆RE@222 vs average volume occupied by aliphatic
side chains of the protein, which was calculated using Expasy Protparam using the structures
from the PDB.
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Interaction of nanosurface with the amino acid side chains after base wash would influence
5

the conformation bound proteins to GO. The possible role of hydrophobic residues in distorting
the structure of the bound protein (between bwGO and GO) is examined in Figure 4.10.B. The
plot of extent of relative structure loss (∆RE@222) as a function of the average aliphatic index
showed a strong correlation. Aliphatic index is the volume occupied by the side chains of
aliphatic amino acids (alanine, valine, isoleucine, and leucine) of the protein. There has been a
greater retention of protein secondary structure with increasing aliphatic index. Base washing
had less and less influence as the aliphatic index increased. That is, more hydrophobic proteins
did not distinguish between bwGO and GO while less hydrophobic proteins are more sensitive
to exposure to the hydrophobic surfaces of bwGO. Thus, the role of OD in these interactions
depends also on the aliphatic index of the protein. In addition, the interaction of bwGO with
biomolecules is primarily hydrophobic, along with weak electrostatic interactions with surface
functional groups.

Enzymatic activities of the proteins after bound to GO and bwGO was another tool used to
compare the effect of OD at this interface. In support with our secondary structure studies,
proteins showed decrease in activities when bound to bwGO vs GO Figure 4.7.A. Peroxidase
like activity of Hb and Mb, Reductase activity of Cat and, Oxidase activity of GOx composites
were decreased at both interfaces and no correlation with charge was noted. Thus hydrophobic
interaction resulted in structure denaturation resulted in loss in activity. Here, as a result of
unfavorable surface interactions with bwGO, most of the enzymes under the study loss its
activity which showed strong correlation with loss in structure.

Further insight into the protein-GO interactions was evident when relative activities of the
bound proteins are compared with their corresponding extents of secondary structure retention.
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Here we observed a linear relation with secondary structure and enzymatic activity for different
proteins (Hb, Mb, Cat and GOx, Figure 4.11). Evidently, structural denaturation is the primary
reason for decrease in activity of the proteins as the debris has been removed. This might seem
trivial as structure retention is essential for activities but it has been noted that GO inhibited the
5

activity of chymotrypsin38 whereas it increased the activity of oxalate oxidase, esterase and
cytochrome c.

10

Since loss in activity is highly undesirable, we tested if the hydrophobic surfaces of bwGO
could be passified by the adsorption of cationized BSA prior to enzyme loading.

10

BSA was

chemically modified with the polyamine, tetraethelenepentamine (TEPA), resulted in a charge
reversal from -20 to +23, confirmed by agarose gel electrophoresis. The bwGO surface
(0.2mg/mL) was passivated using cationized BSA (400% w/w) and, Hb (8 µM), Mb (12 µM), Cat
(0.8 µM) and GOx (4µM) were loaded prior to the activity assays. Activities of the above
enzymes bound to cationized BSA-loaded bwGO (bio-bwGO) is compared with bwGO, under
similar binding conditions, is given in Figure 4.11.B. Surprisingly, the activities of Hb and Mb
bound to bio-bwGO exhibited substantial improvement (Figure 4.11.B, blue bars) while that of
Cat showed no change. Thus, the novel biofunctionalization strategy
to passify bwGO as well.
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Figure 4.11. A. Strong correlation of relative activities of GOx, Cat, Hb and Mb bound to GO or
to bwGO with the extents of their corresponding secondary structure retention. B. Blue bars
correspond to bwGO samples that were biophilized with cationized BSA (bio-bwGO/enzyme)
before enzyme loading.
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Finally, the cell survival studies show that OD affects the interaction of GO with 293T cells.
Incubation for 24 h, both GO and bwGO showed appreciable cytotoxicity above 75 µg/mL
concentration (Figure 4.8). The dose dependent cytotoxicity of GO beyond 75 µg/mL
concentration is in agreement with the previously published results.

23

However, to our

knowledge, there is no study that reported the biocompatibility of bwGO with human cell lines.
Chemically reduced GO, in comparison to GO or bwGO, was much more toxic.39 There has
been no toxicity for OD, even at very high doses (500 µg/mL), which indicates that any toxic
effect of GO is intrinsic to it and not due to OD.
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4.6. Conclusions

The oxidative debris, a by-product of graphene oxide synthesis by any oxidation
method40 was illustrated to affect various mechanical, and optical properties of GO at various
levels. This debris can be separated from GO by washing with any base and the resulted sheets
are called base washed GO (bwGO). Our current study focused on the role of OD in governing
the behaviour of proteins at GO surfaces. Analysis with 13 different proteins of variable
molecular and biological properties revealed that the interactions are more specific to the
protein used. Arginine and aliphatic residues of the proteins controlled the mode of interactions
at GO and bwGO surfaces, indicating the role of hydrogen bonding, electrostatic and
hydrophobic interactions at this interface. The mode of interactions played a major role in
determining the protein secondary structure and thereby dictating the enzymatic activities, which
is crucial for GO based bio-devices. The present study makes some progress in the
fundamental understanding of protein behaviour at graphitic surfaces and the importance of OD
in interpreting protein-GO interactions.
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Biographene: Direct Exfoliation of Graphite to Pristine Graphene
using Proteins

5.1. Abstract

A high yielding aqueous phase exfoliation of graphite crystals to high quality graphene
using edible proteins and kitchen chemistry is reported here. Bovine serum albumin (BSA),
β-lactoglobulin, Ovalbumin, Lysozyme and Hemoglobin were used to exfoliate graphite and
the exfoliation efficiency depended on the sign and magnitude of the surface charge the
protein. BSA, which showed maximum exfoliation rate facilitated graphite exfoliation in
water, at room temperature, by turbulence/shear force generated in an ordinary kitchen
blender at rates exceeding 4 mg mL-1 h-1. Raman spectroscopic analysis and TEM indicated
the presence of 3-5 layer, unoxidized graphene with ~0.5 µm size sheets. When the
dispersions were loaded on a cellulose paper (650 µg cm-2), the film conductivity was
measured to be 32000 S m-1, which is much higher than graphene/polymer composites. Our
method yielded ~7 mg mL-1, stable, pristine graphene dispersions from cheap and
sustainable resources and common apparatus which was stable under wide ranges of pH
(3.0-11) and temperature (5.0-50°C), and in fetal serum for more than a month. Current
approach gave higher rates of biofunctionalized graphene (biographene) with a controllable
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surface charge, in better yields than other methods. These findings might lead to large scale
production of graphene for biological applications.
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5.2. Introduction

A facile route for the large scale production of water dispersible, few layer graphene
(FLG) by shear exfoliation of graphite using inexpensive, edible proteins is reported.
Applications of graphene in the biomedical and healthcare sectors require hydrophilic and
biocompatible graphene derivatives.1 Graphene oxide (GO) is often used as a precursor of
graphene, but its potential is limited by oxidative defects and toxic metallic impurities
introduced during the synthesis and exfoliation process.

2

Although, the successful

exfoliation of graphite to pristine graphene using organic solvents, 3 , 4 ionic liquids 5 , 6 or
surfactants 7 has been reported, the biocompatibility of the resulting product, quality,
expense, and environmental impact of the production methods still remain unaddressed.8

Ultrasonication was used to exfoliate graphene with biological agents such as bovine
serum albumin (BSA).9,10,11 These proteins are suggested to adsorb to graphite platelets and
facilitate delamination upon ultrasonication.9,10,11 The adsorbed protein might inhibit
restacking of the graphene sheets and could contribute to nanoplate stability.11 However,
sonication was suggested to introduce oxidative defects (O - 10-25%),12 scalability of this
process is particularly challenging and only low exfoliation rates have been reported (< 1 mg
mL-1h-1).13

Recently, shear force/turbulence methods were used in a kitchen blender for the
mechanical exfoliation of graphite at rapid exfoliation rates.13,14,15 This method offers low
oxidative damage (O > 5%)15 when compared to the sonication method (O - 10-25%).12 This
approach was mainly used with organic solvents, N-methyl pyrolidine (NMP),13 Dimethyl
formamide (DMF),15 and some surfactants.14 The shear produced and the turbulent flow
exceeds the critical Reynold’s number required for delamination (104),15 and even a simple
kitchen blender was shown to be a feasible apparatus for graphene production.14,15
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Scheme 5.1. A. Shear exfoliation of graphite using bovine serum albumin (BSA) in water at
pH 7.0. B. Type of blades used to generate the turbulence and shear. C. Visualization of
graphene formation by laser light scattering. D. Scalability of the method is demonstrated
where the largest conical flask is 8 L.
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Herein, we report shear-exfoliation of graphite in a kitchen blender with edible proteins
to produce high concentrations of nearly defect-free graphene aqueous dispersions in less
than an hour (Scheme 5.1). By combining the advantages of the protein’s characteristics as
an exfoliating/stabilizing agent for graphene and the feasibility of the shear exfoliation, high
quality graphene is produced rapidly. The proteins we tested for exfoliation efficiency
includes, bovine serum albumin (BSA), β-lactoglobulin, ovalbumin, lysozyme and
hemoglobin, which are inexpensive, edible proteins, and they are either waste products form
the meat industry or from egg and milk.16 The surface charge of the protein played a critical
role in the exfoliation and stabilization of graphene dispersions. Our protein based
shear/turbulence exfoliation is favorable over sonication or organic solvent methods in terms
of yield, quality and water dispersion properties. Our results are described below.
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5.3. Materials and Methods

5.3.1. Materials. Graphite crystals (~150 µm), Lysozyme (egg white), β-lactoglobulin
(Bovine milk), Trypsin (Bovine) and Ovalbumin (egg white) were obtained from Sigma
Aldrich (St. Louis, MO). BSA and Hemoglobin was purchased from Equitech-Bio Inc.
(Kerrville, TX). All the proteins were used without further purification. Oster® Kitchen 10
speed blender was purchased from a local shop.

5.3.2. Exfoliation of Graphite. All the exfoliation experiments were performed by adding
calculated amounts of graphite, BSA, DI water in the kitchen blender at required blade
speed. Aliquots (1 mL) of the mixture were taken every 5 minutes to quantify the progress of
exfoliation. Samples were centrifuged at 1500 rpm for 45 minutes to separate unexfoliated
graphite particles, and the amount of graphene in the supernatant was measured using
extinction at 660 nm, using the calculated extinction coefficient of 398 mL mg-1 m-1 (Figure
5.1). The extinction coefficient of graphene is highly dependent of the size, number of layers
and functionalization present. This extinction coefficient was close to that of polysaccharide
modified graphene.26 Rate of exfoliation at different conditions of concentrations, blade
speed, pH and volume were calculated by following the exfoliation for first 20 minutes. All the
experiments are performed in three trials, except for the optimization of the volume
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Figure 5.1. The calibration plot used to calculate the extinction coefficient (660 nm) of the
biofunctionalized graphene at pH 7.0 in deionized water. All measurements are performed in
triplicates and the error bars are smaller to be visible.
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5.3.3. Raman Spectroscopy. Raman spectra were recorded using a 514 nm laser in
Renishaw system 2000 microscope at 1 µm spatial resolution. The microscope was
calibrated using typical Raman shift of Si-wafer sample at 521 cm-1. Graphene samples were
concentrated using centrifugation to 1 mg mL-1 and were dried on a Si/SiO2 glass with ~1 cm
spot size. We observed sample destruction at 100% focused laser, probably due to the
protein, so the beam was off focused by 50% during the measurement.

The statistical

analysis of number of layers (<NG>) from different Raman spectra was calculated using the
following equation,
0

< 𝑵𝑮 > = 10).+,-.).,/- ,

𝑴 =

𝑰𝑮3 𝒆𝒏𝒆 (𝝎8𝝎𝒑,𝑮3 𝒊𝒕𝒆 )/𝑰𝑮3 𝒆𝒏𝒆 (𝝎8𝝎𝒔,𝑮3 𝒊𝒕𝒆 )
𝑰𝑮3 (𝝎8𝝎𝒑,𝑮3 𝒊𝒕𝒆 )/𝑰𝑮3 (𝝎8𝝎𝒔,𝑮3 𝒊𝒕𝒆 )

(5.1)

where ωp is the 2D peak intensity and ωs is intensity of the shoulder (ωs= ωp–30 cm-1). The
lateral size <L> of the graphene sheets was calculated using the following empirical relation
<𝐿 >=

A

(5.2)

(BC BD )D3 EFE G(BC BD )D3 HIE

where k = 0.17-experimentally calculated by comparing Raman intensities with microscopy
data, and ID/IG is the ratio of D and G band intensities13

5.3.4. Microscopy studies. TEM studies were done in a FEI Tecnai T12 using 100 kV
accelerating voltage. Graphene samples (20 µg mL-1) were drop casted on a Cu-grid and
dried under vacuum, prior to the imaging. SEM images of graphite and graphene coated
paper were taken in a JEOL FESM 6335 using 5 kV accelerating voltage. Samples were
coated with Au-Pd in Edwards E306A Coating System and directly taken for imaging.

5.3.5. Conductivity Measurements. Graphene suspension (4 mg mL-1) was simply coated
on a standard printer paper and air dried to prepare conductive graphene papers. About 200
mg of graphene was adsorbed onto a 22 cm x 14 cm size paper to give 650 µg cm-2 loading.
Sheet conductivity of the paper was measured using a 4-probe measurement in a Keithley
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2420 Sourcemeter®, after making the contacts with Cu-tape. The I-V curve directly obtained
from the instrument was used to find the resistance and the sheet resistance was calculated
using the following formula,22 where R is the resistance, ρ is the resistivity, L is the length, W
is the width and t is the film thickness measured from SEM image.
𝑅= 𝜌

L

(5.3)

MN

5.3.6. Zeta Potential Measurements. Aqueous graphene dispersions (1.6 mL, 0.6 mg mL-1)
with known pH were analyzed using the Brookhaven Zeta Plus zeta potential analyzer
(Holtsville, NY). The samples were analyzed for electrophoretic mobility using laser Doppler
velocimetry and, Smoluchowski fit was used to calculate the zeta potential.
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5.4. Results

A facile method for producing unoxidized, pristine graphene under biologically benign
conditions is essential for widespread biomedical applications of graphene. Rate of
exfoliation, scalability, high quality, controlled functionalization, size and large flake size are
highly desired. Rapid production of biofunctionalized, micron size, and defect free, few layer
graphene (FLG) is reported here.

Further, we have systematically examined particular

experimental variables on the exfoliation process. Our data show that protein charge, both
magnitude and sign, are critical for efficient exfoliation of graphite.

The samples are

extensively characterized and have record high conductance and stability in aqueous media.

5.4.1. Graphite exfoliation with protein solutions. A suspension of graphite crystals
([Graphite] = 100 mg mL-1) in 200 mL deionized (DI) water at pH 7.0 containing the protein
(3.0 mg mL-1) was subjected to shear in a kitchen blender for 30 minutes. Samples were
taken every five minutes to examine the rate of exfoliation and blending was stopped to
avoid overheating (< 30°C). The extinction at 660 nm (E660) of the suspension was used to
quantify the graphene concentrations, after removing the unexfoliated graphite separated by
centrifugation at 1500 rpm for 45 minutes. The extinction coefficient of BSA modified
graphene was 398 mL mg-1 m-1 which was calculated using the calibration plot (Figure 5.1).

5.4.2. Effect of the nature of the protein on exfoliation. The proteins used in this study to
exfoliate graphite were cheap and found in food sources to ensure the biocompatibility of the
produced graphene. BSA (bovine serum), β-lactoglobulin (bovine milk), Lysozyme (egg
white), Ovalbumin (egg white), and Hemoglobin (bovine blood) were used to prove the
hypothesis that proteins are effective tools for biological production of graphene in water.
Four of these five proteins exfoliated graphite, but the exfoliation efficiency strongly
depended on protein charge with BSA giving the highest efficiency (Figure 5.2). Graphene
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production is directly correlated with the extent of negative charge of the protein used.
Therefore, we choose BSA as the model system and systematically evaluated how particular
experimental parameters influence the exfoliation rate.
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Figure 5.2. Plot showing the efficiency of proteins to exfoliate graphite at neutral pH is
correlated with the isoelectric points (pI) of the proteins.

B. Kinetic plot showing the progress

of exfoliation over time using different proteins as stabilizing agents in water.
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5.4.3. BSA concentration dependence. The rate of graphene production (mg h-1), at
constant blade speed of 17 krpm, is plotted against [BSA]o in Figure 5.3.A. As the [BSA]o
increased from 0.50 mg mL-1 to 3.0 mg mL-1 and an increase in rate was observed from 400
to 725 mg h-1 which corresponds to ~4 mg mL-1 h-1 rate of exfoliation. Above 3.0 mg mL-1
[BSA], no significant increase in exfoliation rate was observed and this concentration was
used to optimize the graphite concentration for exfoliation.

5.4.4. Effect of Graphite concentration. The graphite concentration was suggested to
affect graphene production rate, due to collisions between the crystallites which can assist in
exfoliation. Experiments, therefore, were conducted using 20, 40, 60, 80 and 100 mg mL-1
[Graphite]o and fixed [BSA]o (3.0 mg mL-1) in 200 mL DI water at pH 7.0. Exfoliation rate at
17 krpm blade speed was linearly correlated with exfoliation rate as shown in Figure 5.3.B.
The slope of the line displays an increase in the production rate by 6.8 mg h-1 per mg mL-1 of
graphite. Since protein binding to the solid was essential for exfoliation, next we examined
the effect of graphite to BSA concentration ratio (mass/mass) on the exfoliation rate.
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Figure 5.3. Rate of graphene exfoliation as a function of: A. BSA concentration B. Graphite
concentration C. Graphite to BSA concentration ratio. 1, 3 and 8 represents the [BSA]o in
mg mL-1. D. Function of pH E. Function of blade speed and F. function of volume of the
suspension. Some error bars are too small to be visible.
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5.4.5. Effect of graphite to BSA ratio. The effect of graphite to BSA ratio on exfoliation rate
was studied by measuring the exfoliation rate at 15 different ratios of graphite to BSA,
ranging from 0 to 100. Surprisingly, the ratio of BSA to graphite did not influence the
exfoliation rate, but rather depends on initial concentrations ([BSA]o and [Graphite]o) in the
solution (Figure 5.3.C). At lower [BSA]o (1.0 mg mL-1), the exfoliation rate sharply increased
from 170 to 500 mg h-1 as the [Graphite]o was increased from 20 to 100 mg mL-1 (Figure
5.3.B, red lines). The highest exfoliation rate was observed at graphite to BSA ratio of ~33
(mg/mg) at [Graphite]o of 3.0 mg mL-1 (blue lines) , where the [Graphite]o was 100 mg mL-1.
For the next set of the experiments, we increased the [BSA]o to 8.0 mg mL-1 and further
increase has been observed (black lines). Next, we studied the effect of pH in exfoliation
rate.

5.4.6. Effect of pH. Since the graphene stacking may be inhibited by excess charge on the
platelets, we tested the influence of protein charge on exfoliation rate. One simple way to
control protein charge is via pH, and we have examined the exfoliation rate at pHs 1.0, 3.0,
5.0, 7.0 and 9.0 at fixed concentration of BSA (3.0 mg mL-1) and graphite (100 mg mL-1), at
constant volume (200 mL) and constant blade speed (17 krpm). As shown in Figure 5.3.D,
exfoliation rate is strongly dependent on pH, and neutral or alkaline pHs or most favorable.
Exfoliation rate increased from 375 mg h-1 to 725 mg h-1 as pH changed from 3.0 to 7.0. We
suspect that increased negative charge on BSA (pI is 5.3) increases the exfoliation rate.
Next, we examined the effect of blade speed on exfoliation because increased speed
increases the shear forces on the crystallites.

5.4.7. Effect of Blade speed. Since exfoliation is due to the shear produced in the blender,
we examined how the blade speed is related to generating the critical shear force (Reynolds
number - 104) required for exfoliation. The systematic increase in blade speed from 11 to 17
krpm, limited range in a kitchen blender, showed increased exfoliation rate from 375 mg h-1
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to 725 mg h-1 (Figure 5.3.E). A linear fit of the plot suggests 65 mg h-1 per krpm increase
blade speed, which is significant. Further increase in speed is limited by the available
options in a kitchen blender. In addition to the blade speed, the volume of the suspension
also contributes to the shear rate, which is examined next.

5.4.8. Effect of Volume. The change in volume of the exfoliation addresses two
potentially important questions: 1) Is the method scalable by increasing the suspension
volume and, 2) how the shear rate is influenced by the volume. The data show that as the
volume increased from 100 to 1200 mL, the production rate increased monotonously (Figure
5.3.F). At a maximum volume possible in a common kitchen blender (1.2 L), a high rate of
2.4 g h-1 was observed. This demonstrates the possibility for gram-scale production of
graphene by this approach. The increase in volume, however, resulted in decreasing the
effective exfoliation rate from 3.7 mg mL-1 h-1 (at 200 mL) to 2.0 mg mL-1 h-1, at the maximum
volume of 1200 mL. This can be seen as a consequence of the decrease in effective shear
rate because of the increase in volume.14

5.4.9. Characterization of graphene suspensions

The quality of graphene produced is analyzed using Raman spectroscopy,
Transmission electron microscopy (TEM), Scanning electron microscopy (SEM) and
Colloidal stability studies.

5.4.10. Raman Spectroscopy. Raman spectroscopy has been extensively used as a
versatile tool for the characterization of graphene.17 Exfoliation of graphite to graphene, and
the quality of the dispersion was assessed by Raman spectroscopy of dried graphene films
on a glass surface. Typical Raman spectra of graphene (Figure 5.4.A, in blue) showed G
(~1585 cm-1), D (~1350 cm-1) and 2D (2705 cm-1) bands, with significant differences in
intensity and shape, compared to the parent graphite flakes (in red). The signature of 2D
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band was very prominent in the exfoliated samples, i.e. a broader (FWHM ~ 75 cm-1) and
symmetric peak was appeared, in contrast to unsymmetrical graphite (FWHM ~57 cm-1)
peak.

The apparent changes in intensity of Raman peaks give an idea about the size, defect
and number of layers present in the exfoliated graphene.13 Remarkably, the increase in
intensity of D band, which quantitatively represents disorders and edge carbon atoms, has
increased after the exfoliation. An increase in ID/IG ratio from ~0.1 to ~0.6 is observed after
30 minutes of exfoliation. Another noticeable change was the appearance of the shoulder
peak the G band called D’ band, which is activated by defects.17 The increase in intensity of
2D band resulted in I2D/IG ~ 0.9 qualitatively represents the presence of FLG in the
suspension. Further, a statistical analysis of number of layers (NG), lateral size (<L>) and
type of defects in our samples was examined using the Raman intensity ratios (Figure 5.4.C
and D).13

The statistical analysis was perfomed using equation 1 and 2, from the intensity ratios of
six different spectra. The number of layers in the graphene was calculated using the ratio of
I2D to its shoulder peak (I2D – 30 cm-1), which is prominent only in the graphite spectrum
(Figure 5.4.A, red lines). The above ratio in the graphene samples was noramlized with the
ratio of precursor graphite, according to the published empirical formula.13 The analysis gave
NG as 3.6 (±0.4) in the samples, regardless of the exfoliation period (Figure 5.3.B). It is
noteworthy that the Raman spectra are done in dried, precipitated samples, so the cacluated
value would be overestimated, and suggested to be substantiated using microscopy
studies.11,13,17
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Figure 5.4. A. Raman spectra of graphene (blue) in comparison with graphite (red). B.
Change in number layers in graphene with exfoliation time, as calculated using equation (1).
C. Change in lateral size of graphene sheets with exfoliation time, as calculated using
equation (2). D. Raman analysis of graphene showing minor edge defects. All the analysis
were done using six Raman spectral data sets per sample.
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The lateral size of exfoliated graphene is calculated from ID/IG ratios, using Equation
(2)13 as a function of exfoliation time. The average size of the sheets was 0.5 (±.1) µm and
appeared to be highly uniform (Figure 5.4.C). This suggests that the delamination and
fragmentation of the platelets

are happening simultaneously

at the intial stages of

exfoliation process. To futher validate the exfoliation mechanism we carried out the FLG was
subjected to blending for 90 more minutes. The blending of biofunctionalized FLG was
tested for fragmentation and delamination using Raman spectroscopy (Figure 5.5). The
findings suggest that there is no further delamination or fragmentation was occurred at this
step. This supports the recent kinetic theory on exfoliation of 2D materials that the exfoliation
is driven by the delamination multilayared graphite and further exfoliation of FLG is
kinetically unfavorable.18

The ratio of ID to ID’ represents the type of defect(s) present in the graphene.13 The
maginitude of ID/ID’ in our samples was 3.2 (±.6), which is within the range of edge type
defects (Figure 5.4.D). It is very important to note that we do not have any major sp3
defects, which suggests that no oxidation to the sheets was noticed during the exfoliation
process. As such, the Raman studies clearly endorse the successful exfoliation of graphite
to few layer, micron size and defect free graphene. The findings from Raman studies were
further verified using microscopy studies as follows.
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Figure 5.5. Distribution of number of layers (A) , lateral size (B) and defects (C) Few layer
graphene (FLG) subjected to blending after removing unexfoliated graphite. This shows that
further delamination or fragmentation of FLG has not effected by the process.
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5.4.11. Microscopy studies. Transmission electron microscopy (TEM) images were used to
distinguish

the number of layers present in the solution, which confirms the degree of

exfoliation. TEM images were collected using dried, deposited graphene (20 µg mL-1) on a
Cu-grid (Figure 5.7 A-D) and compared with the Scanning Electron Microscopy (SEM)
image of graphite (Figure 5.6) .

Representative images shown in Figure 5.7, suggest the presense of 1-3 layers of
stacked graphene sheets with an average 0.33 micron lateral size. The histogram of the
sheet size measured from 10-15 sheets using diffrerent TEM images is given in Figure
5.7.F. The sheets are found to have a folded or crumbled morphology, which reduces the
average lateral size (Figure 5.7, A-D). This could be the reason for the decrease in average
size (0.33 µm) of sheets measured by TEM (Figure 5.7.F), when compared to Raman
analysis (0.5 µm, Figure 5.4.C). A selected area electron diffrection pattern of the larger
sheet in Figure 5.7.A is shown in Figure 5.7.E , which implied a polycrystalline phase which
could be due to the presence of amorphous BSA functionalization on the sheets and
foldings. Overall, the TEM studies supported the successful exfoliation of graphite to micron
size biofunctionalized FLG.
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Figure 5.6. The SEM images of graphite showing multi layered, micron size platelets.
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Figure 5.7. TEM images of graphene samples show folded (A and B), bi/tri layer distribution
(C and D) in the samples. E. Selected area electron diffraction pattern of folded sheet in A.
F. Histogram showing the size distribution of graphene measured from TEM images.
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5.4.12. Biofunctionalization of Graphene. Production of aqueous graphene dispersions, in
particular, with stability in biological conditions is an active research area in chemical and
biomaterial sciences.

Water stability of graphene derivatives is usually attributed to

hydrophilic modification. Here, by in situ modification of graphene with BSA, we achieved
graphene aqueous dispersions with concentrations as high as 6.8 mg mL-1.

To prove the in situ biofunctionalization, the presence of bound BSA to graphene sheets is
confirmed using UV spectroscopy and zeta potential studies. Due to strong graphene
absorption at 200-300 nm, resolving the 280 nm absorption (A280) of the bound protein was
inconclusive (Figure 5.8.A). Alternatively, we determined the unbound BSA concentration
using A280 after separating the bound BSA by centrifugation (12000 rpm for 45 minutes). We
examined the free [BSA] as a function of the exfoliation time and from that we calculated the
[BSA]bound. We observed that the [BSA]bound gradually increasing (blue lines) as more
graphene was produced in the medium (Figure 5.8.B, inset). Conversely, one can propose
that BSA binding and exfoliation happen simultaneously using this treatment. Nonetheless,
the exchange of BSA from solution to graphene phase proves the in situ biofunctionalization
of graphene.

193

Chapter 5

A

Results

B

Figure 5.8. A. Absorption spectrum of the biofunctionalized graphene. Absorbance at 250400 nm was combined with BSA and the graphene. The combination of absorbance,
extinction and scattering of graphene sheets centered around 600 nm. B.

In situ

biofunctionalization of graphene is confirmed by the exchange of BSA from the solution (red)
to the graphene (blue) with increasing exfoliation time. The increase in graphene
concentration in the system is shown in the inset.
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After 90 minutes of exfoliation, the [BSA]bound was 15 µM which is ~40 % of [BSA]int and
18% (mass/mass) of total graphene concentration (6.8 mg mL-1).

The [BSA]bound

corresponds to 3% area covered by BSA on graphene sheets, assuming that graphene is
monolayer and BSA is completely intact in structure. However, since the graphene is few
layered and BSA showed changes in secondary structure on binding to the graphene
surface (from CD studies, Figure 5.9.A), we propose that 15-20% of the exposed graphene
sheets are functionalized by BSA.
The biofunctionalization was further verified using time dependent zeta potential
measurements shown in Figure 5.9.B We measured the zeta potential of graphene
dispersions as the exfoliation progressed and found that the surface potential was constant
around -27 (± 3) mV at pH 7.0. The observed surface potential of graphene is attributed to
the presence of bound BSA, since the pristine graphene has no sp3 defects due to charged
oxygen functional groups, such as in graphene oxide. This validates the hypothesis that the
protein is been modified to the graphene and the negative charge of BSA is stabilizing the
sheets in the aqueous media.
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Figure 5.9. A. Circular dichroism spectra of BSA after functionalized to graphene (black) in
comparison with unbound BSA showed significant changes in secondary structure. A
quantitative comparison using spectral intensities is limited by the unavailability of precise
[BSA] at the bound state. B. The change in Zeta potential of graphene is plotted as a
function of the exfoliation time. The observed negative zeta potential of graphene is due to
the presence of functioned BSA.
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5.4.13. Colloidal stability of Graphene dispersions. The biological stability of aqueous
graphene dispersions under relevant conditions, with varying temperatures and pHs, and in
fetal bovine serum (FBS) is studied. Stability of graphene/GO dispersions at the
aforementioned conditions depends on the type and degree of functionalization. 19 In the
present study, BSA is the stabilizing agent for graphene, which can undergo structural
changes in stresses such as pH and temperature. 20 Consequently, these changes can
influence the stability of graphene dispersions and this has been investigated by UV-Vis
spectroscopy, and zeta potential studies.
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Figure 5.10. Changes in absorption spectrum of graphene at elevated temperatures.
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Effect of temperature: The role of temperature in the formation of aggregated graphene was
studied in two different aspects. First, we studied the effect of temperature on aggregation at
increasing temperatures from 25 to 80°C by measuring the extinction at 660 nm. There was
no significant change in concentration of graphene (using E660) at elevated temperatures
(Figure 5.10). However, significant spectral changes in the 250 to 400 nm region, occurred
after 60°C, which is noticeably close to the denaturation temperature of BSA.21 An increase
in absorption at 660 nm is also due to the changes in graphene/BSA complex upon
structural changes in BSA. Second, the storage stability of graphene at three different
temperatures (5, 25 and 50°C) in DI water at pH 7.0 was studied by measuring E660 at
specific intervals for more than a month and there has been no aggregate formation (Figure
5.11.A). The E660 of the graphene dispersions after 20 days showed no significant changes.

Biological uses of nanomaterials require stability in biological fluids such as serum. It is
possible that graphene can bind to the biomolecules present in the serum and aggregate,
which would limit its practical uses. We studied the storage stability of graphene in a 50%
FBS solution at 5°C and checked the E660 daily for more than two weeks. There was no
detectable precipitation or aggregation when 50% FBS was added (Figure 5.11.B) but the
E660 showed gradual decrease (Figure 5.11.B).
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Figure 5.11. A. Change in graphene concentration of dispersions stored at 5, 25 and 50°C.
B. Stability of graphene in 50% fetal bovine serum (FBS). C. Zeta potentials of graphene
dispersions as a function of pH.
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After one week, the concentration of graphene was reduced to half of its original value
but retained that concentration for two more weeks with no significant drop. We hypothesize
that this might be due to the activity of the proteases that are present in FBS, which might
deteriorate BSA present on the grapheme sheets and induce aggregation. This was
confirmed by checking the stability of graphene in the presence of a protease, trypsin (0.2
mg mL-1), in DI water at pH 7.4. After one hour of incubation with trypsin at 37ºC, there was
precipitation. Therefore, the protein molecule is necessary for aqueous stability of graphene
sheets, which was noted by other groups as well.10 However, the observed half-life of 10
days in FBS is relevant for biological/cellular studies of graphene. This analysis could
potentially broaden the uses of our graphene in various applications, such as sensing and
toxicity studies in biological fluids.

Effect of pH: The role of pH on graphene stability was studied using zeta potential
measurements. Figure 5.12.A shows the change in zeta potential (ξ) of graphene with pH,
where the observed negative surface charge of graphene is due to the presence of the BSA
functionalization. As the pH decreased from 11 to 2.5 the zeta potential varied from -40 to
+40 mV, and the isoelectric point (ξ =0 mV) was noted at ~ 4.5 which is close to the
isoelectric point of BSA.20 Additionally, the zeta potential of graphene incubated at varying
pHs was measured after incubation at 25 °C for a week. The zeta potential of the solutions
was retained (~100%) after one week (Figure 5.12.A), which proves the colloidal stability of
graphene dispersions over a wide range of pH (3-11). The stability was further supported by
measuring E660 of graphene at the different pHs before and after incubation (Figure 5.12.B).
However, at pH value near ξ =0 mV, aggregated graphene was formed and a substantial
decrease in concentration at pH 5.1 was noted. This emphasizes the crucial role of
electrostatic repulsion between protein molecules in stabilizing graphene in aqueous media.
Also, this study brings out a new opportunity to design biographene with desirable pI values
by using particular proteins for exfoliation.
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Figure 5.12. A. Zeta potential of biofunctionized graphene after incubation at different pHs
showed insignificant changes after a week at 25°C.

B. The absorbance of graphene at

varying pHs. A decrease in absorbance at pH 5.2 was noted because of the aggregation
near the isoelectric point of BSA (5.5).
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5.4.14. Conductivity Measurements. Graphene sheets with few layers and microns of
lateral area have high electrical conductivity.13 The exfoliated graphene was painted onto a
standard printing paper (cellulose) (22cm x 14cm, 650 µg/cm2), and the conductivity has
been measured using standard 4-point probe resistivity, which is more accurate than 2-point
method.22 (Figure 5.13.A and B). The adsorption of graphene onto the paper was confirmed
by SEM images (Figure 5.13.C).

The system showed excellent, continuous conductivity over a range from 0 to 45 V with
a steady output current. The thickness of graphene layer was measured from the crosssectional SEM image (Figure 5.13.C) was 3 µm, which was further confirmed by theoretical
calculation based on the adsorption efficiency (650 µg cm-2) and density of graphite (2.2 g
cm-3). The sheet conductivity of the paper was calculated to be as high as 32,000 S m-1
using Equation 3 (𝑅 = 𝜌 𝐿/𝑊𝑡) with sheet resistance (Rs) of 50 Ω sq-1. High conductivity was
also demonstrated in a circuit connecting an LED and a 12 V battery in Figure 5.13.D.
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Figure 5.13. A. Photograph of graphene-coated paper B. Linear I-V response of the paper
measured using a standard 4-point circuit. C. Representative SEM images of the graphenecoated paper confirming the presence of bound graphene. D. Conductivity of the paper is
illustrated by using the paper in an LED circuit.
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5.5. Discussion

An efficient, simple and robust approach for multi-gram production of biofunctionalized
graphene from graphite, under ambient conditions, is presented here. In this top down
approach, micromechanical exfoliation of graphite was achieved by the shear/turbulence in a
kitchen blender and proteins were used to biofunctionalize pristine graphene sheets. The
aqueous graphene suspensions show storage stability under biologically relevant conditions.

Exfoliation of graphite using biomolecules such as proteins,9,10,11,23 carbohydrates24 and
polysaccharides 25 , 26 offer green, biocompatible carbon based nanomaterials for various
biomedical and drug delivery applications. Recently, proteins such as BSA, lysozyme and
hydrophobins

were

used

for

liquid

phase

ultrasonication.9,10,11
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Figure 5.14. Exfoliation efficiency of different proteins is correlated with A. Charge B. Lysine
(%) C. Arginine (%) D. Hydropathy index and E. Aliphatic index. The analysis suggests that
charge is the key factor in determining the exfoliation efficiency of proteins.
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Proteins are suggested to interact with graphene through hydrophobic residues but the
effect of proteins in stabilizing the dispersions is yet to be established.9 Herein, by using
proteins with different surface (amino acid distribution) and bulk properties (charge and
hydrophobicity), protein charge has been shown to be an important parameter for exfoliation.
Not only protein adsorption on the flakes would be able to reduce the sheet-to-sheet (van
der Waal’s) interactions, but also the charge on the protein is critical for the overall stability
of the functionalized sheets. So, we noted that the proteins with sufficient surface charge (in
our case >-15) showed maximum yield when compared to smaller proteins with less net
charge, such as lysozyme (Figure 5.14). Moreover, we found no correlation with other
parameters such as hydrophilicity, number of charged amino acids and volume of aliphatic
residues in the protein.

In general, sonication based exfoliation was reported to have low exfoliation rates,
cracking of the platelets and their oxidative damage.12 Exfoliation rates by several methods
are compared in Figure 5.15.A. Sonication assisted exfoliation methods, for example, using
BSA, lysozyme and hydrophobins (in 60% ethanol) demonstrated exfoliation rates of 0.27,
0.33 and 0.83 mg mL-1 h-1, respectively.9,10,11 Current approach achieved rates of 4-7 mg mL1

h-1 in a completely aqueous medium, and the exfoliation rate was found to be linear over an

extended period of time (1.5 h, SI Figure 5.8.B). To the best of our knowledge, this is the
highest rate for liquid phase exfoliation in water (Figure 5.15.A). The exfoliation rates were
found to be affected by factors such as 1) [BSA]o, 2) [Graphite]o , 3) pH, 4) total volume, 5)
blade speed, 6) viscosity, 8) surface tension, to name a few. Experiments with varying
[BSA]o and [Graphite]o were conducted while keeping factors 3-6 constant.
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Assuming that the viscosity and surface tension changes are intrinsic to protein
concentrations in our experiments, the following relation for the rate of exfoliation (r) can be
deduced as given in the following equation:

r ∝ 𝐵𝑆𝐴

U

V

× [𝐺𝑟𝑎𝑝ℎ𝑖𝑡𝑒]U a (𝑝𝐻)c (𝑉𝑜𝑙𝑢𝑚𝑒)i (𝑏𝑙𝑎𝑑𝑒 𝑠𝑝𝑒𝑒𝑑)m

where a-e are the corresponding orders of the reaction. Experiments with increasing
[BSA]o showed saturation of exfoliation rate at around 3 mg mL-1 (Figure 5.3.A) and above
this value, ‘a’ is set to zero. But the rate depended more steeply and linearly on [Graphite]o.
This sheds light onto the mechanistic aspect of the exfoliation, in which the graphite-tographite collisions, with threshold Reynolds’s frequency, is rate limiting in the overall
exfoliation process. The bombardment causes fragmentation of the graphite platelets, which
facilitates the shear exfoliation process, because of low van der Waals forces between small
graphene layers.3 In turn, BSA molecules kinetically trap the exfoliated sheets very rapidly
and protect them from restacking. In addition, the other experimental variable pH, volume,
protein charge, and blade speed also contributed to the exfoliation rates (Figure 5.3). We
fitted these data to linear plots (an approximation), and extracted the following values for our
guidance: b=1.2; c=0.29, d=0.99, and e=1.7 in the above equation. Based on these, we
postulate that multiple factors control the exfoliation rate, and it can be maximized in many
dimensions as desired.

BSA plays three other roles in exfoliation: 1) lowering the surface tension of the
medium,27 2) binding to the exposed graphite surface9 and lower its surface free energy, and
3) stabilize the graphene sheets in water by positioning the charged and/or hydrophilic
functional groups for favorable interactions with the solvent or enhance solvation of the
platelets.

28

The intrinsic hydrophobicity of carbon nanomaterials limits their bio-

processability.29 The availability of hydrophilic graphene is largely restricted to GO, which
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was shown to have structural defects, oxidative debris and metallic impurities limiting its
biological use.30 The biofunctionalized grapheme, reported here, was highly stable in water
at various pHs and room temperature, which was not demonstrated in previous studies.
Stability and in vivo and in vitro performance of nanomaterials are challenging due to
aggregation, protein corona formation, and protease activity in biological fluids, particularly in
serum.31,32 Here, the biofunctionalized graphene showed initial aggregation or degradation in
50% FBS due to protease activity but no further changes occurred over several days.
Biographene made here opens up new opportunities to modify its surface with many other
(bio)molecules, as previously demonstrated with GO.33

Electrical conductivity of graphene also depends on the method of exfoliation and the
degree of oxidation. 34 Surprisingly, the BSA coated graphene showed excellent sheet
conductivity, which is 6-7 times better than previously reported graphene based polymeric
composites (Figure 5.15.B).35 Values of 32,000 S m-1 for our biographene coated paper (22
cm x 14 cm) is close to the highest reported value of 45,000 S m-1, in which a relatively
smaller area (5 cm in diameter) was used, and the graphene was produced by GO
reduction, followed by filtration.41 Compared to these other conductive graphene papers
which require laborious filtration, annealing or reduction,39,40,41 this flexible, larger area metalfree conducting sheets indicated some of the highest values, over a large voltage window,
following Ohm’s law. Since many composite films show conductivities over a small voltage
window (usually in mV), our sample has some advantages. The first time illustration of highly
conductive graphene produced by direct exfoliation of graphite is demonstrated here with
edible proteins and a kitchen blender, inexpensive apparatus without using toxic chemicals,
metals or solvents.
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Figure 5.15. A) Comparison of the rate of exfoliation in aqueous media achieved in the
current method with published approaches.

5,9,10,11,14,23,25,26

B) The high conductivity of

biographene deposited on paper when compared to the conductivities of similar
materials.36,37,38,39,40,41 Reference numbers for the corresponding data are shown in each of
the panels.
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5.6. Conclusions

High quality graphene suspended in aqueous media is highly desirable for the biological
applications of this ‘wonder material’. Due to its inherent hydrophobicity, graphene needs
adequate biofunctionlization for its dispersion in water. Proteins were recently used as the
exfoliating agents, as well as modifiers, to yield aqueous graphene dispersions via
ultrasonication, which gave slow exfoliation rates (< 1 mg mL-1 h-1), limited scalability (<100
mL) but induced basal plane defects (O content of 10-25%).12,13 Breaking of the sheets,
production of reactive sites and reaction of the damaged sites with oxygen were suggested
to be some of the disadvantages of sonication.12

To overcome these disadvantages,

shear/turbulence forces were used as a successful alternative, although, to date, the
approach has been limited to organic media and surfactant solutions.

Here, the exciting possibilities of shear/turbulence method were coupled with the
surface active properties of edible proteins and produced multi-gram scale synthesis of
unoxidized, low-defect graphene suspensions in water. The protein charge played a key role
in exfoliation of graphite, the strongly negatively charged BSA showed maximum efficiency.
The GO or chemically reduced GO (rGO) used is prepared by tedious oxidation/reduction
treatments; contaminate the GO with metallic or other impurities.2 The biographene is
obtained directly from graphite and proteins, which could be an alternative to GO or rGO for
a variety of applications. Moreover, this approach could be extended to many other proteins,
as desired for particular applications.

Herein, the graphene concentration as high as 7 mg mL-1 was achieved, at high rates of
exfoliation, and exfoliation rate is tied with specific attributes of the reaction medium for
future scale-up. An empirical relation was deduced for further optimization of the exfoliation
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rates. Biographene with particular isoelectric points or tunable charge can be produced by
selecting appropriate proteins for the exfoliation or by controlling the pH of the medium.

These suspensions also showed long-term thermal, pH and storage stabilities under
biologically relevant conditions, including in a biological fluid (fetal serum) which a very good
test for biological applications. These aqueous graphene dispersions, with improved
biological stability, could be good alternatives to widely used GO or rGO for a variety of
applications in biomedical and bioengineering fields. 42 The biographene-coated cellulose
paper is unique in that it is the first conductive, metal-free cellulose-protein-graphene hybrid
material that has not been reported before. This simple exfoliation method could lead to
greater access of graphene for laboratories with limited resources or applications that need
large quantities, and it could further revolutionize the graphene field.
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